Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Month: April 2026

ChiroMedBlog2026April

DHEA: Enhancing Your Well-Being With Hormonal Health

Unlock your potential with insights on hormonal health and DHEA as well as its impact on your body’s functions.

Abstract

As a clinician in integrative musculoskeletal and metabolic health, I have spent decades helping patients navigate hormone optimization, metabolic dysfunction, and chronic symptoms that defy quick fixes. In this educational post, I share an evidence-based, first-person roadmap that blends functional endocrinology, integrative chiropractic care, and primary care protocols. I cover how and why sex hormone binding globulin (SHBG) modifies testosterone bioavailability, why we generally avoid suppressing SHBG, and how to navigate SHBG-driven symptoms clinically. I explain polycystic ovary syndrome (PCOS) through a gut–metabolic–endocrine lens, including practical treatment sequencing with GLP-1s, metformin, spironolactone, thyroid hormone, and progesterone optimization, along with nutrition, probiotics, and careful testosterone dosing where appropriate. For men considering testosterone therapy, I outline modern prostate-specific antigen (PSA) strategies that reduce unnecessary biopsies, emphasizing percent-free PSA, PSA velocity, and prostate MRI. Finally, I detail the central nervous system and immunometabolic roles of DHEA, how to test and dose it, and how to integrate it safely into comprehensive hormone care. Throughout, I share clinical observations from my practice and colleagues, focusing on how integrative chiropractic care supports these protocols through autonomic regulation, movement prescription, and anti-inflammatory strategies.

Introduction: Building A Foundation For Smarter Hormone Care

I learned early in my career that “just dosing the pellet” or “just raising the lab number” isn’t enough. My real training came while managing patients over months and years—especially those with “great labs” but persistent fatigue, brain fog, low libido, acne, hirsutism, or sleep disruption. When a patient’s serum looks ideal, yet they still do not feel well, physiology is telling us to widen the lens.
Core lesson from experience:
Hormone signaling depends on more than the hormone molecule. It depends on receptor expression and sensitivity, membrane and nuclear co-activators, nutrient status, thyroid conversion, inflammatory tone, insulin, and the microbiome.
Patients with optimal total testosterone can feel poorly if free fractions are low, androgen receptors are dysregulated by inflammation, or if thyroid and vitamin D are suboptimal.
A vivid case taught me the leverage of micronutrients. Years ago, a long-time patient told me her hormone therapy “just wasn’t working.” Her labs were good; her symptoms were not. We discovered she had stopped taking her vitamin D. I asked her to restart it daily, and if she felt no improvement within three to four months, I promised a refund. She returned about three and a half months later, noticeably improved. “I will never stop vitamin D again.” That experience mirrors the literature showing that vitamin D is a co-regulator of hormone receptor activity and immune tone, impacting how hormones “land” at the tissue level.
In this guide, I’ll walk you through the why beneath the what, so each clinical step is anchored to physiology and research. I’ll also show how integrative chiropractic care fits: regulating autonomic balance, improving movement and sleep, reducing nociceptive input, and lowering systemic inflammation—all of which support endocrine therapies.

Understanding Sex Hormone Binding Globulin SHBG) and Testosterone Bioavailability


Why SHBG Matters


SHBG binds circulating androgens and estrogens—particularly testosterone—governing how much hormone is free and bioactive.
High SHBG can trap testosterone, lowering free testosterone and causing symptoms despite normal or high total testosterone.
Low SHBG often signals metabolic dysfunction. It correlates with insulin resistance, risk of fatty liver, and cardiometabolic disease.

Key Physiology


SHBG is produced in the liver. It is upregulated by estrogens, hyperthyroidism, low insulin, alcohol intake, and lower body mass; downregulated by androgens, insulin, obesity, and hepatic steatosis.
SHBG acts as more than a passive binding protein. Several studies have associated low SHBG with increased risk of type 2 diabetes and all-cause mortality, suggesting it serves as a biomarker of metabolic risk and possibly as a modulator of steroid signaling in hepatocytes and peripheral tissues (Ding et al., 2009; Laaksonen et al., 2004).

Clinical Reasoning: Do Not Reflexively Lower SHBG


Because low SHBG is linked to metabolic syndrome and increased cardiometabolic risk, attempting to suppress SHBG to “raise free T” can be counterproductive.
Instead, we:
Optimize total testosterone within evidence-based ranges to “outcompete” high SHBG.
Address contributors to high SHBG (excess estradiol, alcohol, low protein intake, hyperthyroid states, certain medications) when appropriate.
Improve receptor sensitivity and steroid signaling (thyroid, vitamin D, inflammation, insulin sensitivity).
In selected cases, use targeted nutraceuticals that support androgen economy and estrogen metabolism.

Practical Strategies to Overcome High SHBG


Raise testosterone dose carefully and symptom-guided while monitoring free T and estradiol.
Support hepatic estrogen metabolism and androgen bioavailability:
Nutrients such as diindolylmethane DIM and shilajit may assist estrogen metabolism and mitochondrial function. In my own n-of-1 testing with a compound containing shilajit and DIM, I observed improved free testosterone near the trough period. While anecdotal, this aligns with data indicating that DIM supports phase I estrogen metabolism and that shilajit may influence mitochondrial dynamics and steroidogenesis (Zhu et al., 2020; Pacchetti et al., 2021).
Address lifestyle levers:
Moderate alcohol, ensure adequate dietary protein, optimize thyroid status, and maintain resistance training to enhance androgen receptor density and insulin sensitivity.

Why Integrative Chiropractic Care Helps Here


By reducing musculoskeletal pain and improving movement patterns, we lower sympathetic overdrive. Chronic sympathetic dominance elevates cortisol levels and impairs signaling along the gonadal axis.
Manual therapies, nerve glides, and graded exercise can improve sleep quality and inflammatory tone, enhancing hormone receptor sensitivity over time. In practice, we see better outcomes when patients combine hormonal optimization with structured movement, fascial care, and recovery protocols.

SHBG As A Metabolic Biomarker


Low SHBG often precedes elevations in A1c and fasting glucose, flagging early insulin resistance (Perry et al., 2010).
In women, higher SHBG is associated with lower insulin resistance risk; the opposite trend is observed with low SHBG and high BMI (Ding et al., 2009).

Takeaway


Use SHBG diagnostically, not just therapeutically. Let it inform your metabolic plan. Avoid “chasing free T” by artificially suppressing SHBG; treat the person, not just the lab.

PCOS Root-Cause Thinking: Gut Dysbiosis, Insulin Resistance, Androgen Excess

The Modern PCOS Lens

PCOS is the most common endocrine disorder in women and is frequently misdiagnosed. Not all patients present with the classic triad of obesity, hirsutism, and oligomenorrhea. About half are not overweight.
Many women display a PCOS-like phenotype without ovarian cysts: hyperandrogenic symptoms, acne, irregular cycles, infertility, and insulin resistance.
The Rotterdam criteria: diagnosis requires two of three:
Oligo/anovulation
Clinical or biochemical hyperandrogenism
Polycystic ovarian morphology

Physiology: Gut–Immune–Endocrine Crosstalk


Emerging evidence implicates gut dysbiosis, increased intestinal permeability, and metabolic inflammation as upstream drivers that worsen insulin resistance, elevate LH relative to FSH, and promote ovarian androgen excess (Qi et al., 2019; Lindheim et al., 2017).
Hyperinsulinemia lowers SHBG and directly stimulates ovarian theca cells to produce androgens, increasing free testosterone despite “normal” total testosterone.
Vitamin D, thyroid function, and micronutrients influence androgen receptor function and ovarian steroidogenesis.


Clinical Picture I See Often


Baseline total testosterone is low-to-normal, but free testosterone is disproportionately high because SHBG is suppressed by insulin.
LH: FSH ratio may be >2:1 in some patients. Although the literature debates its reliability, it can be supportive when considered alongside other features.
Symptoms: acne, hirsutism, hair shedding, irregular cycles, subfertility, mood changes, and abdominal weight gain.

An Integrative Treatment Plan That Works


Fix the gut basics first.
Ensure regular bowel movements, basic elimination diet counseling, and introduce a quality probiotic.
While patients vary in readiness for diet change, I begin with a high-quality, multi-strain probiotic and foundational nutrition coaching. Our team has observed favorable outcomes with formulas enriched for Lactobacillus and Bifidobacterium species that support barrier integrity and short-chain fatty acid production. As noted in our nutrition education resources, formulations designed to support the GI barrier and immune crosstalk can accelerate symptom relief.
Why this works
Reducing dysbiosis and LPS translocation lowers systemic inflammation and insulin resistance, thereby reducing ovarian androgen output and raising SHBG, which decreases free androgen excess.
Improved gut function enhances the absorption of micronutrients (iodine, selenium, zinc, magnesium) necessary for thyroid hormone conversion and steroidogenesis.
Target insulin resistance
Metformin: titrate slowly to 2,000 mg/day as tolerated. Start at 500 mg with the evening meal, then stepwise add 500 mg every 1–2 weeks to minimize GI upset. The goal is 1,000 mg twice daily, extended-release when possible.
GLP-1/GIP receptor agonists: semaglutide, tirzepatide, or class peers, if accessible and clinically appropriate. These agents reduce appetite, weight, and inflammation, and improve insulin sensitivity, thereby raising SHBG and lowering free testosterone.
Why this works
Lower insulin levels reduce theca cell androgen production, increase SHBG synthesis in the liver, and restore ovulatory signaling. Over time, menses regularity and ovulatory function return. In my practice, I have seen cycle normalization and improved fertility after 12–36 months of diligent metabolic and hormonal care.
Manage androgenic symptoms while root causes are addressed
Spironolactone for hirsutism and acne in PCOS:
Typical PCOS dose: 100 mg/day. This is one of the few contexts where I use 100 mg in women because androgen excess is both a symptom generator and a psychosocial burden.
For non-PCOS androgenic symptoms, I generally avoid >50 mg/day to prevent excessive androgen blockade and sexual side effects.
Topical options can support acne management.
Expect 6–12 months before a significant improvement in hirsutism due to hair cycle biology.
Protect pregnancy and fertility.
Progesterone support is critical. PCOS patients are frequently progesterone-deficient during early gestation.
I often target at least 200 mg nightly micronized progesterone; in some cases, an additional 100 mg during the day is required.
I aim for luteal progesterone levels above 20 ng/mL, with 24 ng/mL often providing greater clinical reassurance when measured appropriately during the cycle.
Thyroid optimization matters. Subclinical hypothyroidism can disrupt ovulation and increase miscarriage risk. Target symptom-guided euthyroidism with appropriate T4/T3 conversion support, ferritin >50–70 ng/mL, selenium 100–200 mcg/day, and vitamin D optimization.
Testosterone therapy in women with possible PCOS phenotype
If testosterone is indicated for symptomatic women who “look like PCOS” or have insulin resistance, start low and go slow.
In my practice, I avoid starting doses above approximately 75–87.5 mg when using implants in such patients and titrate carefully. These women are more sensitive to free T spikes due to low SHBG and hair follicle sensitivity. Overshooting increases acne and hirsutism.
Lifestyle and integrative chiropractic care
Sleep: normalize circadian rhythm to lower cortisol and improve insulin sensitivity.
Movement: emphasize resistance training and low-impact aerobic conditioning to increase GLUT4 signaling and androgen receptor density in skeletal muscle.
Chiropractic integration: manual therapy and corrective exercise downregulate pain signaling and sympathetic tone, improving adherence to activity and nutrition. At our clinic, blending spinal and regional biomechanics with metabolic counseling improves durability of outcomes and patient engagement (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).


PCOS Outcomes


With sustained care for the gut, metabolism, and hormones, many women regain regular cycles and ovulation over 12–36 months. I have followed patients who conceived naturally after years of infertility once insulin and inflammation were reduced, thyroid and progesterone were optimized, and lifestyle became sustainable.

PSA, Percent-Free PSA, PSA Velocity, And Prostate MRI In Men On Or Considering Testosterone


What Changed in the Last Decade


PSA alone is an imperfect cancer biomarker: specific but not sensitive. Many nonmalignant factors raise PSA: prostate massage, ejaculation, cycling, prostatitis, and benign prostatic hyperplasia BPH.
Percent-free PSA improves sensitivity. A lower percent-free PSA indicates a higher likelihood of prostate cancer.
PSA velocity matters. A rapid rise from baseline is more concerning than an isolated value.


How I Screen and Refer


Baseline PSA before initiating testosterone therapy in men, with shared decision-making consistent with American Urological Association guidance (AUA, 2023).
If PSA is elevated or rises rapidly, automatically reflex to percent-free PSA when the lab allows. Many laboratories can set an auto-reflex rule when PSA exceeds 4.0 ng/mL; you can request this configuration.

Interpreting Percent-Free PSA


Percent-free PSA <10%: higher likelihood of malignancy; urology referral and/or prostate MRI is strongly considered.
Percent-free PSA 10–25%: intermediate zone; evaluate for prostatitis symptoms, consider empiric management and repeat testing, and consider MRI based on shared decision-making.
Percent-free PSA >25%: lower likelihood; monitor and reassess.

Remember Finasteride

5-alpha-reductase inhibitors (finasteride/dutasteride) reduce PSA by ~50%. Double the measured PSA to estimate the “true” value for risk assessment.

PSA Velocity Example

A jump from 0.9 to 2.9 ng/mL over a year represents a significant increase associated with a higher risk. Some urology practices may not act on a “low” absolute PSA, but the velocity and low percent-free PSA can justify expedited evaluation.

Multi-parametric has become the preferred next step

Multi-parametric prostate MRI is now a gold-standard triage tool. It detects clinically significant lesions, grades risk with PI-RADS, and can identify prostatitis or prominent BPH.
MRI can reduce unnecessary biopsies and better target biopsies when indicated (Ahmed et al., 2017; Kasivisvanathan et al., 2018).
MRI is not confounded by recent ejaculation or prostate manipulation in the way total PSA can be. Percent-free PSA also remains stable relative to such perturbations.

Clinical Pathway I Use


Baseline PSA and DRE as indicated.
If PSA is above the threshold or velocity is high:
Order percent-free PSA.
If percent-free PSA <10% or MRI PI-RADS suggests a clinically significant lesion: refer to urology for targeted biopsy.
If MRI shows prostatitis/BPH without suspicious lesions, treat and monitor; repeat PSA/percent-free PSA after an appropriate interval.
Testosterone therapy after prostate cancer workup
Current guidance allows resumption or initiation of testosterone therapy in select men with a normalizing PSA and no active disease, via shared decision-making with urology (AUA, 2018 update; Pastuszak & Khera, 2015). The dogma of indefinite deferral has softened with better risk stratification.

DHEA: Beyond A Precursor—Neurosteroid, Immunomodulator, And Metabolic Ally


What We Now Know


Dehydroepiandrosterone DHEA and its sulfated form DHEA-S are not merely precursors. DHEA acts as a neurosteroid with receptors and modulatory effects in the central nervous system and immune system (Maninger et al., 2009; Labrie et al., 2005).
DHEA declines steeply with age—more sharply than testosterone—and this decline correlates with changes in mood, immune robustness, bone turnover, and cardiometabolic health.

Physiology Highlights

Source: adrenal zona reticularis and, to a lesser degree, CNS synthesis.
Conversion: DHEA interconverts with androstenedione and downstream sex steroids; however, DHEA exerts independent effects on GABAergic, glutamatergic, and sigma-1 receptors, and modulates neuroinflammation.
Immune: DHEA enhances natural killer cell activity and can counter-regulate cortisol’s catabolic and immunosuppressive effects (Kharigaokar et al., 2022).
Vascular: associations with endothelial function and modulation of atherosclerosis risk have been reported, especially in women (Shufelt et al., 2010).

Clinical Uses I Have Found Most Impactful


Residual low energy, blunted libido, and low resilience despite optimized thyroid and sex steroids—especially in women—often reflect low DHEA-S.
Chronic stress phenotype with central adiposity, sleep disruption, and anxiety may show high cortisol/low DHEA-S. Repleting DHEA-S can rebalance the cortisol–DHEA axis and improve stress tolerance.

Testing and Target Ranges


Test DHEA-S, not just DHEA. DHEA-S is more stable and better reflects adrenal throughput.
Laboratory “normal” ranges are wide and population-based. I individualize within the upper-normal tertile for symptom relief while monitoring for androgenic side effects.
Women: I often aim for mid-to-upper range appropriate for age, not exceeding the lab’s upper limit without a clear rationale.
Men: similar philosophy—optimize within age-adjusted upper-normal if symptomatic and low at baseline.

Dosing Strategy

Start low, reassess, titrate slowly. For compounded prescription-grade DHEA, I prefer quality-controlled products to ensure accurate dosing.
Women: 5–25 mg/day, commonly 10–20 mg/day. Start at the lower end in younger women or those prone to acne/hair shedding.
Men: 25–50 mg/day, commonly 25–40 mg/day.
Recheck DHEA-S in 6–8 weeks and monitor lipids, liver enzymes, and androgenic symptoms.
Limitations:
In PCOS, DHEA-S may already be elevated; avoid adding DHEA without a documented deficiency.
Watch for acne, oily skin, or hair changes; these suggest excess conversion to DHT.

Why It Works

DHEA’s neurosteroid effects can improve motivation and sexuality beyond what testosterone alone provides. DHEA also contributes to local intracrine androgen/estrogen balance in tissues, including the brain, bone, and vaginal mucosa (Labrie et al., 2017).
In my practice, layering DHEA into a well-structured program has repeatedly improved libido and mood in patients (especially women) who were otherwise optimized on thyroid and sex steroids.

Integrative Chiropractic Care: The Missing Link In Hormone Outcomes

The Autonomic–Endocrine Connection

Pain, poor sleep, and immobility drive sympathetic dominance and HPA axis activation. Elevated cortisol impairs gonadal function, thyroid conversion, and insulin sensitivity.
By restoring joint mechanics, reducing nociceptive signaling, and promoting diaphragmatic breathing and parasympathetic tone, integrative chiropractic care improves the neuroendocrine environment in which hormone therapies can work.


How We Implement It

Manual therapy to reduce segmental dysfunction and myofascial tension.
Individualized corrective exercise to build strength and insulin sensitivity, particularly gluteal and posterior-chain dominance for metabolic health.
Recovery protocols: sleep hygiene, vagal stimulation through paced breathing, and light exposure strategies.
Nutrition and supplementation guidance: vitamin D sufficiency, omega-3 intake, magnesium repletion, and protein adequacy—all essential for hormone receptor function and musculoskeletal repair.
Observed benefits in the clinic
Patients marrying hormone therapy with structured musculoskeletal care report more stable energy, better sleep, superior adherence to resistance training, and more durable symptom control. In our practice, this integrated plan consistently outperforms hormone-only or exercise-only approaches (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).

Putting It All Together: A Stepwise Protocol


Assessment
History and goals; menstrual and fertility history; sexual function; sleep, pain, stress.
Labs:
CBC, CMP, fasting insulin, fasting glucose, A1c, lipid panel, and hs-CRP.
Thyroid panel with TSH, free T4, free T3, thyroid antibodies as indicated.
25-hydroxyvitamin D.
Total testosterone, free testosterone, estradiol, SHBG.
DHEA-S.
In men: PSA with reflex percent-free PSA if available; note finasteride.
Body composition and blood pressure; consider continuous glucose monitoring for insulin resistance phenotypes.
Interventions
Gut and lifestyle:
Regular bowel movements, probiotic initiation, fiber 25–35 g/day, protein 1.2–1.6 g/kg/day, omega-3 repletion, and vitamin D to 40–60 ng/mL.
Resistance training 2–4x/week; low-impact cardio; sleep 7.5–8.5 hours; alcohol moderation.
Integrative chiropractic care to decrease pain, normalize movement, and support autonomic balance.
Insulin resistance:
Metformin was titrated to 2,000 mg/day as tolerated.
GLP-1 or GLP-1/GIP agonists where appropriate and accessible.
Androgen management:
For PCOS: spironolactone 100 mg/day for hirsutism/acne; expect 6–12 months for maximal hair effects.
Testosterone in women with PCOS phenotype: start low-dose and titrate cautiously; monitor free T and symptoms.
Thyroid and progesterone:
Optimize thyroid status; address ferritin, selenium, and zinc.
Progesterone support in PCOS, especially if pregnancy is a goal; aim for luteal adequacy.
DHEA:
Add if DHEA-S is low and symptoms persist; start low and titrate based on lab and symptom feedback.
Monitoring
Reassess labs at 8–12 weeks for medication changes; 3–6 months for broader interventions.
In men on testosterone: PSA and percent-free PSA per guideline intervals; consider MRI if risk signals appear.
Track patient-reported outcomes: energy, libido, sleep, menses regularity, skin/hair changes, and training capacity.
Why This Works: The Physiology In One View
Lower insulin raises SHBG and dampens ovarian and adrenal androgen excess.
Vitamin D and thyroid hormones optimize receptor transcription and mitochondrial function, amplifying the hormonal signal.
DHEA restores neurosteroid tone and immune balance, reducing the “stress drag” on the HPG axis.
Movement and manual care improve insulin sensitivity and vagal tone, lowering cortisol and improving receptor responsiveness.
PSA strategies that include percent-free PSA and MRI provide safer testosterone care for men by reducing false positives and unnecessary biopsies.

Closing Thoughts

I began this work focused on “getting the number right.” Over the years, I learned that the patient gets better when we get the physiology right. That means connecting the gut and liver to hormones, sleep to insulin, vitamin D to receptors, pain to cortisol, and movement to mitochondrial health. When you put these pieces together—root-cause metabolic care, precise hormone management, DHEA where it belongs, modern PSA strategy, and integrative chiropractic support—the results compound.

Citations

  • Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M.K., multi-parametric M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer PROMIS: a paired validating confirmatory study. The Lancet. https://doi.org/10.1016/S0140-6736(16)32401-1
  • American Urological Association. (2018, updated 2023). Early Detection of Prostate Cancer: AUA Guideline. https://www.auanet.org/guidelines/early-detection-of-prostate-cancer
  • Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2009). Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. https://doi.org/10.1001/jama.2009.130
  • Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., … & PRECISION Study Group. (2018). MRI-targeted or standard biopsy for prostate cancer diagnosis. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1801993
  • Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2005). DHEA and intracrinology. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2005.08.002
  • Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., … & Plante, M. (2017). Efficacy of intravaginal DHEA on moderate to severe dyspareunia. Menopause. https://doi.org/10.1097/GME.0000000000000801
  • Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T. P., Valkonen, V. P., … & Salonen, J. T. (2004). Sex hormones, SHBG, and metabolic syndrome in middle-aged men. Diabetes Care. https://doi.org/10.2337/diacare.27.5.1036
  • Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone DHEA and DHEA-sulfate DHEAS. CNS Drugs. https://doi.org/10.2165/00023210-200923070-00004
  • Pastuszak, A. W., & Khera, M. (2015). Testosterone therapy after prostate cancer. The Journal of Urology. https://doi.org/10.1016/j.juro.2014.09.110
  • Perry, J. R., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., … & Frayling, T. M. (2010). Genetic evidence that raised sex hormone binding globulin SHBG) Levels reduce the risk of type 2 diabetes. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq316
  • Qi, X., Yun, C., Pang, Y., & Qiao, J. (2019). The impact of the gut microbiota on the reproductive system. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaz013
  • Shufelt, C., Bretsky, P., Almeida, C. M., Johnson, B. D., Shaw, L. J., Azziz, R., & Bairey Merz, C. N. (2010). DHEA-S levels and cardiovascular disease mortality in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0302
  • Zhu, B. T., Lee, A. J., & Conney, A. H. (2020). Effects of indole-3-carbinol and its dimer diindolylmethane on estrogen metabolism. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.29488
  • Pacchetti, B., Ghezzi, L., & Galimberti, D. (2021). Shilajit: a herbo-mineral exudate for mitochondrial health. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.656924

Refermulti-parametric


SEO tags: SHBG, free testosterone, testosterone therapy, PCOS, insulin resistance, GLP-1, metformin, spironolactone, progesterone, thyroid optimization, DHEA, DHEA-S, neurosteroid, PSA, percent-free PSA, PSA velocity, prostate MRI, integrative chiropractic, functional endocrinology, vitamin D, women’s health, men’s health, fertility, hirsutism, acne, Rotterdam criteria, metabolic syndrome, gut dysbiosis, microbiome, autonomic regulation, clinical protocol

Personalized Hormone Optimization and Health Support

Personalized Hormone Optimization and Health Support

Personalized Hormone Optimization and Health Support

Abstract

In this educational post, I share my integrative, evidence-based approach to optimizing hormones for women and men—focusing on how declines in testosterone, estradiol, and progesterone can drive anxiety, irritability, sleep fragmentation, low libido, metabolic resistance, and chronic pain. I explain the physiology behind these symptoms, how I layer therapies to honor receptor sensitivity and avoid side effects, and how to select the right route—pellets, injections, patches, creams/gels, or sublingual—based on your goals and biology. I also show how integrative chiropractic care supports autonomic balance, neuromuscular health, and inflammation control, thereby enhancing hormone therapy outcomes. Throughout, I highlight current findings from leading researchers and share clinical observations from my practice to provide you with a clear, practical roadmap you can use with your care team.

Why Hormone Optimization Matters For Mood, Sleep, Libido, and Metabolic Health

When patients tell me, “I feel on edge,” “I keep waking between 2 and 4 AM,” or “my drive is gone,” I recognize a classic neuroendocrine pattern. Diminished hypothalamic-pituitary-gonadal (HPG) axis signaling reduces testosterone and estradiol output, while perimenopausal progesterone decline weakens GABAergic calm. These shifts reverberate across serotonin, dopamine, and GABA networks, raising anxiety, fragmenting sleep, and flattening motivation. Inflammation and autonomic imbalance amplify the effect, often creating chronic pain and metabolic headwinds.

What this means physiologically:

  • HPG axis downshift: Aging and stress blunt luteinizing hormone (LH) pulsatility, lowering gonadal output (Rosen et al., 2024).
  • Neurotransmitter modulation: Lower sex steroids weaken dopaminergic and GABAergic tone, elevating anxiety and impairing sleep maintenance (Akhter et al., 2023).
  • Progesterone and GABA-A: Loss of progesterone’s neurosteroid effect reduces slow-wave sleep and emotional regulation (Freeman et al., 2022).
  • Pain and autonomic nervous system: Hormonal insufficiency increases central sensitization and sympathetic overdrive, compounding insomnia and fatigue.

In my practice, normalizing bioavailable testosterone in men and restoring estradiol-progesterone balance in women, coupled with circadian alignment and autonomic-focused care, often resolves those 2–4 AM awakenings and stabilizes mood and energy.

My Stepwise, First-Person Roadmap: Layering Therapies With Precision

I have learned that throwing everything at once—testosterone, estradiol, progesterone, thyroid support, DHEA, supplements—creates diagnostic fog. Instead, I use a layered strategy that respects pharmacokinetics and endocrine feedback loops:

  • Start with the most likely driver based on symptoms and labs.
  • Add one or two interventions at a time.
  • Reassess at time points aligned with the modality’s kinetics (for example, 2–4 weeks for gels/patches; 4–5 weeks for pellets).
  • Adjust carefully using validated symptom scales (e.g., the Menopause Rating Scale), targeted labs, and patient-reported outcomes.

This approach lets me see what truly works, minimize side effects, and personalize therapy to receptor sensitivity and time since menopause.

References: Menopause Rating Scale (Heinemann et al., 2004)

Testosterone: Why It Matters For Men And Women

Testosterone is not just about muscle; it is a neuro-metabolic hormone:

  • Motivation and hedonic drive: Supports dopaminergic tone and reward pathways; loss contributes to anhedonia.
  • Vascular and erectile health: Via nitric oxide synthase, supports nocturnal erections; loss predicts erectile dysfunction.
  • Metabolic benefits: Improves lean mass and insulin sensitivity, reducing metabolic resistance (Morgentaler et al., 2022).
  • Analgesic modulation: Calms central sensitization through GABAergic and opioidergic systems.

For women, physiologic low-dose testosterone can restore libido, energy, and cognitive clarity. However, women are more sensitive to peaks and cumulative exposure. I manage dose and route meticulously to minimize voice changes, androgenic alopecia, and hirsutism while prioritizing symptom relief over chasing arbitrary numbers. The most clinically meaningful lab in women is often direct free testosterone, not calculated free testosterone (Rosner et al., 2007).

References:

Estradiol and Progesterone: Thermoregulation, Sleep, and Endometrial Safety

Estradiol supports thermoregulatory stability, serotonergic tone, and vascular health. Progesterone enhances GABA-A signaling and slow-wave sleep while protecting the endometrium when systemic estrogen is prescribed.

  • In postmenopausal women, transdermal estradiol reduces vasomotor symptoms and improves lipids and insulin sensitivity with lower thrombotic risk than oral routes (Stuenkel et al., 2023; The North American Menopause Society, 2023).
  • Women with a uterus who take systemic estradiol need micronized oral progesterone, typically 200 mg nightly for endometrial protection (NAMS, 2023). Progesterone creams are not sufficient for this purpose.
  • In perimenopause, estradiol fluctuations are the rule. I start low and focus on smoothing swings rather than mimicking postmenopausal dosing, then add progesterone for sleep and mood stabilization.

References:

Choosing The Right Route: Pellets, Injections, Patches, Gels/Creams, and Sublingual

Pellets: Continuous, Steady-State Delivery

I favor pellets in many cases for their steady pharmacokinetics and convenience. Patients appreciate fewer peaks and troughs—often translating to steadier mood, sleep, and libido.

  • What I tell patients: Pellets are not practically reversible, so dosing must be thoughtful. Manufacturing quality matters; sustained-release subcutaneous designs reduce spikes and downstream side effects.
  • Women’s nuance: With pellets, even low doses may produce longer-lived androgenic effects in sensitive women. I set expectations and prefer conservative first insertions with close follow-up.

Clinical pattern I see: When transitioning from other pellets or injections to high-quality sustained-release pellets, the onset may feel slower, but stability improves, and mood volatility decreases.

Injections: Predictable for Men, Risky Peaks if Undersmoothed

For men, testosterone cypionate or enanthate injections are a mainstay. Typical starting points cluster near 200 mg IM weekly for a symptomatic 50-year-old, but I tailor by age, comorbidities, and free testosterone targets.

  • Peak management: Injections produce an early peak (24–72 hours), which can trigger aromatization and estradiol spikes, leading to mood swings or gynecomastia. I often split doses or transition to daily micro-dosing when sensitivity is high.
  • Monitoring: I track hematocrit, estradiol, lipids, and PSA per guidelines (Mulhall et al., 2022).

References:

Patches and Transdermal Creams/Gels: Absorption and Site Matters

Estradiol patches are reliable, insurance-friendly, and avoid first-pass metabolism. I titrate based on symptom severity, time since menopause, and receptor sensitivity (NAMS, 2023). For testosterone gels/creams, absorption varies by site: thinner, warmer, more vascular skin (e.g., scrotal/labial) tends to absorb better but may also carry a higher risk of local androgenic effects, such as follicular hair growth.

  • Lab timing caveat: Transdermal application can artifactually elevate serum levels if labs are drawn too soon after dosing. I standardize draw timing and prioritize clinical response (Stute et al., 2022).

References:

Sublingual/Rapid-Dissolve Tablets (RDT)

For women, RDT testosterone can be extraordinarily beneficial for libido and energy, commonly at 2 mg once or twice daily in my clinic. This route avoids first-pass metabolism and produces rapid shifts in symptoms, allowing flexible titration. For men, daily RDT requirements are often too high to be practical.

Clomiphene and Fertility-Preserving Strategies in Men

Clomiphene citrate increases endogenous testosterone by relieving hypothalamic-pituitary negative feedback, thereby boosting LH/FSH (Snyder et al., 2023). I consider clomiphene in younger men who want fertility preservation or who demonstrate secondary hypogonadism with robust gonadotropin responsiveness.

  • Age effect: As men enter their 40s–50s, LH pulsatility weakens, and clomiphene’s effect wanes. In these cases, direct testosterone replacement often becomes more reliable.

Reference:

Perimenopause, Menopause, and FSH: Dosing Strategy In Context

A pivotal question I ask every time is: Are cycles still occurring? Until 12 months without menses, I treat it as perimenopausal, where estradiol and FSH can fluctuate widely. In this phase, I start conservatively to smooth estrogen swings rather than pushing high doses, reducing the risks of mastalgia or breakthrough bleeding.

Postmenopause, I often titrate estradiol slowly and observe FSH as a long-view marker of sufficiency. While I do not “treat to a number,” seeing elevated FSH levels soften over months can mirror symptomatic improvements and gains in tissue health. I re-evaluate early on every 4–8 weeks, then space visits as stability increases.

References:

SHBG, Free Hormone, and Why Symptoms Lead

Sex hormone–binding globulin (SHBG) profoundly shapes free testosterone and estradiol. High SHBG can blunt clinical effects; low SHBG can magnify them. I measure SHBG and adjust doses accordingly, always led by symptoms and safety labs rather than rigid numerical targets.

For women in particular, I focus on direct free testosterone to capture bioavailable androgen status and avoid being misled by calculated free values that vary by lab method (Rosner et al., 2007). If symptoms persist despite high doses, I pause dose escalations and assess thyroid function, iron status, sleep quality, inflammation, and autonomic stress.

Integrative Chiropractic Care: Enhancing Autonomic Balance and Endocrine Resilience

Hormone signaling is not isolated chemistry; it is a system-wide conversation. Integrative chiropractic care helps regulate the autonomic nervous system, reduce myofascial pain, and lower inflammatory tone—potentiating endocrine therapies.

What I do in practice:

  • Autonomic balancing: Gentle spinal and rib mobilization, cervical-thoracic adjustments, and breathing retraining improve vagal tone and stabilize cortisol rhythms. Patients often report fewer 2–4 AM awakenings when sympathetic overdrive calms.
  • Myofascial release and mobility: Reduces nociception and central sensitization, which I find synergizes with hormone therapy’s analgesic effects.
  • Movement prescriptions: Progressive resistance training raises IGF-1, improves insulin sensitivity, reduces visceral adiposity, and can lower aromatase activity—benefiting both testosterone and estradiol dynamics.
  • Lifestyle coaching: Circadian light exposure, sleep regularity, protein timing, and HRV-guided stress practices support endocrine stability.

Clinical observations from my practice at ChiroMed:

  • Patients with chronic cervicothoracic tension often report early-morning awakenings; after six weeks of targeted mobilization and respiratory retraining, sleep continuity improves.
  • Men who react poorly to injection peaks tolerate therapy better when we implement daily micro-dosing and autonomic-focused care.
  • Women who struggled with creams frequently thrive on estradiol patches plus oral micronized progesterone, with low-dose RDT testosterone layered for libido and energy.

Supportive references:

Practical Protocols: Matching Route to Patient Needs

For Men

  • Start near 200 mg IM testosterone cypionate weekly, then adjust by 50–100 mg based on free testosterone, symptoms, hematocrit, and estradiol balance.
  • If sensitive to peaks, consider split injections or daily micro-dosing.
  • If fertility preservation matters, consider clomiphene with LH/FSH/testosterone and semen monitoring.
  • Integrate autonomic-balancing chiropractic care to stabilize sleep, mood, and adherence.

For Women

  • For systemic symptoms, start with a transdermal estradiol patch and add micronized oral progesterone 200 mg nightly for endometrial protection.
  • For libido/energy, add low-dose testosterone via RDT (e.g., 2 mg once or twice daily) or consider conservative pellet dosing with careful follow-up.
  • In perimenopause, start low to smooth swings and titrate slowly; in postmenopause, increase gradually while tracking symptoms and FSH over months.

Monitoring framework:

  • Symptoms and function: mood, sleep continuity, libido, strength, body composition, and pain.
  • Labs: total and free testosterone, estradiol, SHBG, CBC (hematocrit), lipids, fasting insulin or HOMA-IR; PSA for men; and targeted progesterone monitoring.
  • Reassess at 6–8 weeks early in therapy, then every 3–6 months.

Side Effects and How I Mitigate Them

  • Hirsutism (women): Lower dose, change route (e.g., RDT instead of pellets), or split dosing to avoid peaks.
  • Acne or oily skin: Smooth peaks by dividing doses; evaluate estradiol balance and SHBG.
  • Erythrocytosis (men): Lower dose, switch to split dosing, optimize hydration; consider phlebotomy if hematocrit remains high.
  • Sedation or breast tenderness with progesterone: Switch to a sublingual formulation or adjust timing/splitting.
  • Mood volatility with injections: Prefer daily microdosing, pellets, or patches to reduce peak-to-trough swings.

Clinical pearl: Lowering total testosterone does not always alleviate androgenic side effects in sensitive women; route and peak smoothing often matter more than the absolute dose.

Special Topics: Menstrual Migraine, SSRIs, and Lab Timing

  • Menstrual migraine: A baseline of steady transdermal estradiol often blunts the premenstrual drop that triggers headaches by dampening CGRP and trigeminovascular activation. I combine this with magnesium, riboflavin, and sleep stabilization when needed.
  • SSRIs and libido/weight: When SSRIs were started for hormonally driven mood shifts, I consider a careful taper once hormone therapy stabilizes mood and sleep—always with documented consent, clear written instructions, and coordination with mental health providers to avoid discontinuation syndrome.
  • Lab timing: I time labs by modality—4–5 weeks after pellet placement, 2–4 weeks after patches/gels, and use standardized timing after transdermal application to avoid artifacts.

References:

Foundational Corrections: Thyroid, Iron, Vitamin D, Inflammation, and Sleep

Hormone therapy works best on a solid physiologic foundation. I routinely evaluate and correct:

  • Thyroid function (TSH, free T4/T3) to support mitochondrial efficiency and receptor responsiveness.
  • Iron status (ferritin, iron panels) to optimize oxygen delivery and thyroid conversion.
  • Vitamin D for immune and endocrine modulation.
  • Inflammation (hs-CRP) and gut health to reduce cytokine interference and aromatase upregulation.
  • Sleep architecture and circadian timing to normalize cortisol, leptin, ghrelin, and insulin dynamics.

Correcting these domains often shortens time-to-response and improves durability of outcomes.

Clinical Vignettes From My Practice

  • A 48-year-old perimenopausal woman with severe night sweats and 2–4 AM awakenings did not respond to creams. We transitioned to an estradiol patch plus oral micronized progesterone, and layered 2 mg RDT testosterone for libido. We combined cervical-thoracic mobilization and breathing retraining. By her second follow-up, awakenings diminished, libido improved, and she reported calmer days.
  • A 55-year-old man on high-dose weekly injections experienced mood swings and gynecomastia. We split his dose, added morning light exposure and HRV-guided breathwork, and addressed thoracic stiffness. Symptoms eased, energy stabilized, and labs normalized.
  • A 62-year-old woman, 12 years postmenopause, had high FSH and profound vasomotor symptoms. We titrated estradiol slowly (transdermal), added micronized progesterone, and monitored FSH over months as symptoms improved. Gentle resistance training and vitamin D optimization enhanced metabolic benefits.

Safety, Shared Decision-Making, and Documentation

  • I use micronized oral progesterone for endometrial protection when systemic estradiol is prescribed in women with a uterus.
  • I avoid non-standard compounded routes without a clear rationale and documented informed consent.
  • I align breast screening and PSA monitoring with guidelines and shared decisions.
  • I standardize follow-up intervals, written instructions (e.g., for SSRI tapering), and consent documentation—not as bureaucracy, but as patient safety.

Putting It All Together: A Modern, Integrative Pathway

  • Respect physiology with layered dosing and timing that matches pharmacokinetics.
  • Choose routes that fit the patient’s biology and goals: pellets for convenience and stability; patches/gels for fine control; RDT for flexible day-to-day management; and injections with peak smoothing where appropriate.
  • Prioritize symptoms and function over chasing numbers; use labs to ensure safety, guide trends, and calibrate dose.
  • Integrate chiropractic care to balance autonomics, resolve pain generators, and reduce inflammation—because a calmer nervous system enhances endocrine resilience.
  • Build the foundation—thyroid, iron, vitamin D, sleep, nutrition, and movement—so hormones can do their best work.

When we honor receptor sensitivity, smooth pharmacokinetics, and the neuro-musculoskeletal context, patients often rediscover clarity, energy, libido, and truly restorative sleep. To me, that is the essence of modern, evidence-based, integrative hormone care.

References

Hormone Health, Metabolism, and Prostate Wellness

Hormone Health, Metabolism, and Prostate Wellness

Hormone Health, Metabolism, and Prostate Wellness

Abstract

In this educational post, I take you through a practical, clinician-tested roadmap to understanding and treating hormone-related metabolic dysfunctions across the lifespan—particularly the interplay among sex hormone–binding globulin (SHBG), insulin resistance, polycystic ovary syndrome (PCOS), DHEA dynamics, and prostate-specific antigen (PSA) decision-making for men’s health. Drawing on current research and my clinical observations at Chiromed and in integrative practice, I explain why SHBG is not your enemy, how gut-driven insulin resistance amplifies androgen effects, how to identify PCOS phenotypes that do not look “typical,” and how to merge modern therapeutics (GLP-1s, metformin, spironolactone) with lifestyle, nutrition, and integrative chiropractic care to restore function. I also walk through PSA interpretation using percent free PSA and velocity, and when to order a 3T multiparametric prostate MRI. You will find physiologic context, step-by-step reasoning, and practical protocols you can apply immediately.

Key topics that follow

  • SHBG physiology, clinical meaning, and why chasing a lower SHBG is usually counterproductive
  • Insulin resistance, the gut–ovary axis, and PCOS phenotypes and treatment logic
  • Practical dosing pearls for metformin, GLP-1 receptor agonists, and spironolactone
  • DHEA physiology, neurological roles, and targeted use in men and women
  • PSA, percent free PSA, velocity, and the role of 3T multiparametric MRI
  • Where integrative chiropractic, movement therapy, and neuromusculoskeletal care fit into endocrine-metabolic care plans

Understanding SHBG, Free Testosterone, and Metabolic Health

I often meet patients who are symptomatic for low testosterone despite “normal” total testosterone. The missing piece is frequently sex hormone–binding globulin (SHBG)—a carrier protein synthesized in the liver that binds androgens (with a higher affinity for testosterone than for estradiol) and regulates the amount of hormone that is free and bioavailable to occupy intracellular receptors.

Core physiology, clearly explained

  • SHBG binds circulating androgens. Bound hormone is transport-ready but not freely available to cross the cell membrane and activate intracellular androgen receptors.
  • The fraction that remains free (or loosely albumin-bound) is bioavailable and exerts physiologic effects in target tissues (muscle, brain, bone, skin, reproductive organs).
  • Hepatic SHBG synthesis is modulated by insulin, estrogen, and thyroid status. Hyperinsulinemia suppresses SHBG; estrogen and thyroid hormone tend to raise it.
  • Clinically, a low SHBG often signals insulin resistance, while a higher SHBG is frequently associated with favorable metabolic profiles.

Why this matters clinically

  • Patients with low SHBG often present with features of metabolic syndrome—even when A1c still looks “fine.” Multiple cohorts show that low SHBG is a predictive marker for insulin resistance, dysglycemia, and cardiometabolic risk in both women and men (Ding et al., 2009; Selva et al., 2007).
  • Chasing a lower SHBG to “free up” testosterone usually misses the root cause and may worsen risk. Raising insulin (e.g., by overeating refined carbohydrates) can drop SHBG, but at a clear metabolic cost.

Evidence snapshot

  • Prospective data indicate that low SHBG predicts incident type 2 diabetes in women and men independent of BMI and baseline glucose (Ding et al., 2009).
  • Mechanistically, hepatic insulin signaling downregulates SHBG gene expression (Selva et al., 2007), providing a direct pathway from insulin resistance to low SHBG.

Treatment logic you can trust

  • Goal: Improve insulin sensitivity and the liver’s metabolic set point rather than artificially forcing SHBG down.
  • When symptomatic hypogonadism coexists with low SHBG, you may need to “saturate” androgen receptors by optimizing total testosterone so that the available free fraction reaches clinical effectiveness. The parallel, long-term fix is to address metabolic drivers that normalize SHBG.

Integrative chiropractic fit

  • In our practice, optimized movement patterns, resistance training, and autonomic balance through chiropractic care and neuromusculoskeletal rehabilitation improve insulin sensitivity, lower systemic inflammation, and support hepatic health—mechanisms that indirectly help normalize SHBG. I find that restoring spinal mechanics and reducing pain enables patients to engage in consistent physical activity, a cornerstone for improving insulin signaling (see my practice observations at Chiromed).

PCOS, Insulin Resistance, and the Gut–Ovary Axis

PCOS is one of the most common endocrine disorders in women of reproductive age. Yet, it is easy to miss because many patients lack the classic triad of obesity, acne, and hirsutism. I routinely see athletic women with irregular cycles, dysmenorrhea, or infertility—sometimes the only obvious clue—who nonetheless have the hormonal signature of PCOS.

Current diagnostic framework

  • Rotterdam criteria: Diagnose PCOS when at least 2 of 3 are present:
    • Oligo- or anovulation (e.g., irregular or skipped cycles)
    • Clinical/biochemical hyperandrogenism (e.g., hirsutism, acne, elevated free testosterone)
    • Polycystic ovarian morphology (PCOM) on ultrasound
  • Note: Not all patients have ovarian cysts, and total testosterone may be normal while free testosterone is elevated due to low SHBG.

Useful lab patterns

  • Elevated LH: FSH ratio (often >2:1) in some premenopausal patients.
  • Low or low-normal SHBG, elevated free testosterone; often high DHEA-S in adrenal-dominant phenotypes.
  • Early insulin abnormalities and low SHBG can precede changes in A1c.

Why insulin resistance drives PCOS

  • Hyperinsulinemia stimulates theca cells in the ovary to increase androgen production while simultaneously suppressing hepatic SHBG synthesis, thereby increasing free androgens (Escobar-Morreale, 2018).
  • Gut dysbiosis and endotoxemia (LPS exposure) promote low-grade inflammation and worsen insulin signaling, propagating ovarian dysfunction (Zhang et al., 2019).

Atypical PCOS phenotypes I see

  • Lean, athletic women with:
    • Severe dysmenorrhea or irregular cycles
    • Elevated LH: FSH
    • High free T with normal total T
    • High DHEA-S
    • Minimal or no hirsutism/acne

This pattern demands a gut–metabolic workup even when body composition appears healthy. I frequently include stool microbiome testing when symptoms suggest dysbiosis.

Evidence-Based Treatment Algorithms for PCOS

My approach integrates metabolic therapy, targeted pharmacology, nutrition, and neuromusculoskeletal care.

  1. Normalize insulin signaling
  • Metformin: Start low (e.g., 500 mg nightly) and titrate slowly to 1,500–2,000+ mg/day as tolerated to reduce hepatic gluconeogenesis and improve insulin sensitivity. GI side effects often attenuate with gradual titration and extended-release forms (Rena et al., 2017).
  • GLP-1 receptor agonists (e.g., semaglutide, exenatide): Improve glucose-dependent insulin secretion, delay gastric emptying, reduce appetite, and facilitate weight loss; randomized trials show improved metabolic and reproductive outcomes in PCOS (Kahal et al., 2021; Elkind-Hirsch et al., 2008).
  • Mechanistic payoff: Lower insulin raises SHBG and reduces androgenic “noise,” restoring ovulatory signaling.
  1. Manage androgenic symptoms while root-cause care takes hold
  • Spironolactone: An aldosterone antagonist with androgen receptor–blocking activity; effective for hirsutism, acne. Typical doses 50–100 mg/day; allow 6–12 months for maximal effect (Brown et al., 2009).
  • Combined oral contraceptives (COCs) with antiandrogenic progestins (e.g., drospirenone-containing formulations) can raise SHBG and reduce free T; useful for cycle control and symptom relief when pregnancy is not desired (Teede et al., 2018).
  • Caution: Symptom control does not correct the insulin–ovary axis; keep metabolic therapy central.
  1. Nutrition, gut health, and inflammation
  • Anti-inflammatory, Mediterranean-style diet with adequate protein, fiber, and omega-3 fatty acids improves insulin sensitivity and reduces ovarian androgen production (Barrea et al., 2019).
  • Intermittent fasting (time-restricted eating) may improve insulin sensitivity and weight in appropriately selected patients; ensure adequate caloric intake and avoid in those with disordered eating tendencies (Patterson & Sears, 2017).
  • Microbiome support: Address dysbiosis, SIBO, and intestinal permeability where indicated; diet, prebiotic fiber, and evidence-based probiotics can improve metabolic parameters.
  1. Movement and integrative chiropractic
  • Consistent resistance training and aerobic exercise improve GLUT4 translocation, mitochondrial function, and insulin sensitivity. In my clinic, we pair individualized spinal and joint care with corrective exercise to reduce pain-related movement avoidance and enhance adherence.
  • Autonomic balance matters: Many PCOS patients show sympathetic dominance; hands-on care and breathing-based neuromuscular retraining can reduce allostatic load and support ovulatory recovery.
  1. Fertility trajectory
  • Expect cycles and ovulation to normalize over months to years as insulin sensitivity improves. I have seen patients regain regular ovulation and conceive after systematic, sustained metabolic and gut care—even in those previously considered “lean and healthy.”

Clinical pearls and cautions

  • Start androgen therapy cautiously in PCOS or insulin-resistant women with low SHBG. Given the higher free fraction, standard doses can overshoot, increasing the risk of side effects. Start low and titrate slowly if testosterone therapy is clinically indicated for other reasons.
  • Obtain LH and androgen panels in premenopausal patients with menstrual complaints or infertility—even if phenotype is nonclassic.
  • Consider GI testing (e.g., stool analysis) when symptoms or history suggest dysbiosis, IBS, or food-triggered inflammation.

SHBG: What to Avoid and What to Embrace

Common misconception

  • “Lower SHBG to increase free T.” This treats the lab number, not the disease process.

What to avoid

  • Strategies that raise insulin (e.g., high refined carbohydrate load) just to lower SHBG.
  • Unnecessary suppression of SHBG may worsen cardiometabolic risk.

What to embrace

  • Improve insulin sensitivity through nutrition, exercise, sleep optimization, stress modulation, and gut care.
  • Use medications like metformin and GLP-1 receptor agonists to shift the metabolic field when lifestyle alone is insufficient.

In my practice, when we prioritize insulin sensitivity and inflammation control, SHBG trends upward into healthier ranges, free testosterone normalizes relative to total testosterone, and symptoms improve without chasing lab artifacts.

PSA, Percent Free PSA, and Prostate MRI: Smarter Men’s Health

PSA screening has evolved. A single total PSA value is an imperfect signal. Two tools improve decision-making:

  • Percent free PSA (%fPSA): The fraction of PSA not bound to serum proteins. Lower %fPSA indicates a higher likelihood of malignancy at a given total PSA.
  • PSA velocity: The year-over-year change in PSA. Faster rises suggest higher risk.

How I interpret PSA in practice

  • If total PSA is elevated (e.g., >4.0 ng/mL), I obtain percent free PSA. General rules supported by meta-analyses:
    • %fPSA <10% = higher probability of prostate cancer
    • %fPSA 10–20% = intermediate zone; consider prostatitis treatment if symptomatic and retest in ~3 months
    • %fPSA >20% = lower probability; continue surveillance
  • Consider PSA velocity: An increase >0.35–2.0 ng/mL/year—context-dependent—merits further evaluation even if the absolute PSA is “within range” (Vickers et al., 2011).
  • Many benign factors elevate total PSA—intercourse, cycling, digital stimulation, BPH, prostatitis—but they do not significantly affect %fPSA, which is why I lean on percent free PSA for triage.

Imaging that changes outcomes

  • If risk remains concerning (low %fPSA, rapid velocity, suspicious DRE, or persistent PSA elevation), I order a 3 Tesla multiparametric prostate MRI (mpMRI). This modality improves lesion detection and helps target biopsies, reducing unnecessary procedures (Ahmed et al., 2017).
  • Most patients prefer an MRI over immediate biopsy, and mpMRI adds diagnostic clarity, including detection of chronic or acute prostatitis—a common cause of PSA bumps that I diagnose frequently.

Practical pearls

  • Finasteride lowers total PSA by roughly ~50% but does not meaningfully change %fPSA—interpretation should be adjusted accordingly.
  • Counsel patients to avoid prostate stimulation (e.g., ejaculation, vigorous cycling) for 48–72 hours before PSA sampling to reduce noise in total PSA.
  • If PSA and %fPSA suggest low risk, recheck in 3 months rather than rushing to biopsy.

Testosterone therapy timing

  • When PSA and urologic evaluation are reassuring, testosterone therapy can proceed with routine monitoring. I coordinate closely with urology, recognizing that practice styles vary.

DHEA Physiology, Brain Receptors, and When to Treat

Dehydroepiandrosterone (DHEA) and its sulfated form, DHEA-S, are produced primarily by the adrenal cortex and function as both endocrine prohormones and neurosteroids, with receptors and actions in the brain. Levels peak in the 20s and decline steadily with age. In both sexes, suboptimal DHEA can present as low vitality, depressed mood, impaired stress tolerance, and reduced sexual function—even when testosterone looks “good.”

Why DHEA matters

  • Neurosteroid action: DHEA modulates GABAergic and glutamatergic tone, supporting mood, cognition, and arousal (Maninger et al., 2009).
  • Peripheral conversion: DHEA can be converted to androgens and estrogens via tissue-specific enzymes; in women, a portion is converted to DHT in peripheral tissues, contributing to libido and sexual response.
  • Immunometabolic effects: DHEA has anti-inflammatory properties and may influence endothelial function and bone metabolism.

Clinical patterns I see

  • Women with adequate total and free testosterone who remain symptomatic for low libido or anorgasmia sometimes have low DHEA-S in the double digits. Carefully titrated DHEA supplementation often improves sexual function and overall well-being.
  • In men and women with persistent fatigue and low mood despite thyroid/hormone optimization, DHEA can be the missing link.

Dosing logic

  • I typically optimize thyroid and sex hormones first; DHEA often rises when metabolic stress decreases.
  • If DHEA-S remains suboptimal:
    • Women: 5–10 mg/day compounded DHEA; reassess at ~6 weeks
    • Men: 20 mg/day compounded DHEA; reassess at ~6 weeks
    • Over-the-counter options vary in potency; when used, I start around 25 mg/day with close follow-up.
  • Monitor for androgenic side effects, especially in PCOS (who often already have high DHEA-S); avoid in hyperandrogenic phenotypes.

Evidence notes

  • Studies link low DHEA-S to reduced well-being, depression, and sexual dysfunction, with improvements seen in targeted supplementation cohorts (Arlt et al., 1999; Wierman et al., 2014). Age-associated decline is robust and correlates with multiple health outcomes.

Why Integrative Chiropractic Care Belongs in Endocrine-Metabolic Programs

The neuromusculoskeletal system interfaces with the endocrine and immune systems through shared inflammatory and autonomic pathways. Here is how integrative chiropractic care fits, based on observations from my clinic and the scientific literature:

Mechanistic bridges

  • Inflammation: Chronic pain amplifies IL-6 and TNF-α signaling, worsening insulin resistance. By reducing nociceptive drive and improving joint mechanics, manual therapies can lower inflammatory load and facilitate activity.
  • Autonomic balance: Spinal and rib mechanics influence sympathetic/parasympathetic tone. Improved thoracic mobility and diaphragmatic function promote vagal activity, which supports glycemic control and gut motility—both key to the gut–ovary axis.
  • Movement competency: Targeted strength and mobility programs enhance GLUT4 activity in skeletal muscle, thereby improving insulin sensitivity and supporting healthy SHBG levels.

In practice at Chiromed

  • We build individualized plans that synchronize:
    • Spinal and extremity joint care to enable pain-free training
    • Progressive resistance training emphasizing posterior chain and hip mechanics
    • Aerobic conditioning at sustainable intensities
    • Breathing retraining and sleep hygiene to normalize cortisol rhythms
  • This approach improves adherence to metabolic prescriptions, enabling the nutrition and pharmacology to “land” in real life.

Search-optimized section title Practical Protocols and Case-Style Reasoning

Putting it all together, here is how I apply the logic in daily care.

When SHBG is low, and symptoms suggest androgen deficiency

  • Evaluate metabolic health: fasting insulin, lipids, liver enzymes, hs-CRP, A1c.
  • Address insulin resistance first-line with nutrition, exercise, sleep, and stress management; consider metformin and/or GLP-1 RAs.
  • If symptoms persist, carefully optimize testosterone with awareness that low SHBG increases free fraction—start low, titrate to symptom relief and physiologic targets.

When PCOS is likely, but the phenotype is atypical

  • Order LH, FSH, total and free T, SHBG, DHEA-S, fasting insulin/glucose, and consider stool testing.
  • Begin metabolic therapy plus symptom-directed therapy (spironolactone or COCs if appropriate and pregnancy not desired).
  • Integrate resistance training and chiropractic-guided movement plans to accelerate insulin sensitivity and ovulatory recovery.

When initiating or adjusting DHEA

  • Confirm suboptimal DHEA-S and symptom alignment (low mood, libido, vitality).
  • Start low, reassess in 6–8 weeks, and monitor for androgenic side effects.
  • Avoid in hyperandrogenic PCOS unless clearly indicated and monitored.

When PSA is elevated or changing fast

  • Obtain percent free PSA and calculate velocity.
  • If %fPSA <10% or velocity is concerning, proceed to 3T mpMRI; if prostatitis is suspected, treat and retest.
  • Collaborate with urology based on mpMRI and clinical findings; delay testosterone changes until evaluation clarifies risk.

Why We Use Each Technique: The Physiology Behind the Protocols

  • Metformin: Reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity via AMPK activation; lowers insulin, allowing SHBG to normalize and free T to calm down.
  • GLP-1 receptor agonists: Enhance glucose-dependent insulin secretion, reduce appetite, and reduce systemic inflammation; improved ovulatory function reported in PCOS.
  • Spironolactone: Direct androgen receptor blockade plus inhibition of 5α-reductase at higher doses; symptom relief while metabolic causes are corrected.
  • DHEA: Restores neurosteroid tone and supports sexual function with selective peripheral conversion; used when clinically and biochemically indicated.
  • Integrative chiropractic and movement: Improves neuromechanics and reduces pain, enabling training volume and intensity that improve insulin sensitivity; enhances autonomic balance affecting gut and endocrine axes.

Final Takeaways for Patients and Providers

  • Think metabolically first: Low SHBG is often a metabolic distress signal, not a target to suppress.
  • PCOS can be lean and subtle: Free T, LH: FSH, and DHEA-S mapping, plus gut assessment, can catch atypical cases.
  • Combine symptom control and root-cause therapy: Use spironolactone or COCs for hirsutism/acne while you restore insulin sensitivity and gut health.
  • Use smarter PSA strategies: Percent free PSA and PSA velocity reduce unnecessary biopsies and guide timely imaging with 3T mpMRI.
  • Integrate care: When manual therapy, structured exercise, and metabolic medicine are aligned, recovery timelines shorten and outcomes improve.

References

Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M. K., … Emberton, M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet, 389(10071), 815–822.

Arlt, W., Callies, F., van Vlijmen, J. C. M., Koehler, I., Reincke, M., Bidlingmaier, M., … Allolio, B. (1999). Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine, 341(14), 1013–1020.

Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., De Alteriis, G., Colao, A., & Savastano, S. (2019). Nutritional aspects of PCOS: an update. Advances in Nutrition, 10(2), 270–292.

Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, (2), CD000194.

Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C.-C., Rifai, N., … Liu, S. (2009). Sex hormone–binding globulin and risk of type 2 diabetes in women and men. JAMA, 301(17), 1777–1786.

Elkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008). Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in obese polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 93(7), 2670–2678.

Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Human Reproduction Update, 24(6), 671–698.

Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., & Kilpatrick, E. S. (2021). The effect of GLP-1 receptor agonists on cardiovascular risk factors in women with PCOS. Endocrine, 71, 199–206.

Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of DHEA and DHEA-S. Psychoneuroendocrinology, 34(3), 273–286.

Patterson, R. E., & Sears, D. D. (2017). Metabolic effects of intermittent fasting. Annual Review of Nutrition, 37, 371–393.

Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Nature Reviews Molecular Cell Biology, 19(1), 31–44.

Selva, D. M., Hogeveen, K. N., Innis, S. M., & Hammond, G. L. (2007). Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin gene. Journal of Clinical Investigation, 117(12), 3979–3987.

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., … International PCOS Network. (2018). Recommendations from the international evidence-based guideline for the assessment and management of PCOS. Human Reproduction, 33(9), 1602–1618.

Vickers, A. J., Savage, C., O’Brien, M. F., Lilja, H. (2011). Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. Journal of Clinical Oncology, 29(33), 447–453.

Failure to Yield Left-Turn Accidents: Injury Recovery

Failure to Yield Left-Turn Accidents: Injury Recovery

Failure to Yield Left-Turn Accidents: Injury Recovery

A ChiroMed Guide to T-Bone Crashes, Injury Recovery, and Restoring Mobility

A “Failure to Yield Left Turn” accident happens when a driver turns left across active traffic before the road is truly clear. In many of these crashes, the turning vehicle ends up partially blocking the lane, and the front of the oncoming vehicle strikes the side of the turning vehicle. That is why this crash is often called a “T-bone” or side-impact collision. Under Texas law, a driver turning left must yield the right of way to oncoming traffic that is already in the intersection or close enough to be an immediate hazard. (Texas Legislature, 2025; Daniel Stark, 2026).

For ChiroMed patients, this matters because side-impact crashes often create more than one injury at the same time. The force can twist the neck, compress the shoulder, jar the lower back, and strain the soft tissues on one side of the body. ChiroMed describes its model as a multidisciplinary, patient-centered approach led by Dr. Alex Jimenez, a dual-licensed chiropractor and advanced practice nurse practitioner, offering services including chiropractic care, rehabilitation, acupuncture, nutrition, and treatment for whiplash and severe auto accident injuries. (ChiroMed, 2026).

What This Crash Is Really Called

The best way to understand this crash is to separate the legal problem from the physical impact.

  • Failure to Yield Right of Way: This is a legal violation when a left-turning driver enters the path of oncoming traffic.
  • T-bone collision: This describes the shape of a crash in which one vehicle strikes the side of another.
  • Side-impact collision: another common term for the same type of hit.
  • “Sticking out” accident: This is an informal description people use when the turning car is left protruding into an active lane.
  • Improper median or lane positioning: In some cases, the driver also misuses the median opening or fails to line up correctly before finishing the turn. Texas DPS materials include “improper lane or location – median” as a recognized offense-code description. (Texas DPS, 2009; TopDog Law, 2025; DCM&D Law, 2026).

So, in simple terms, the crash is usually a T-bone collision caused by failing to yield when making a left turn. If the vehicle is hanging out in the crossover or median break, poor positioning may also be part of the story. That technical detail can matter when police, insurers, and injury providers are trying to understand exactly how the crash happened. (Texas DPS, 2009; Texas Legislature, 2025).

Why Failure to Yield Left Turns Are So Dangerous

Left turns are risky because the driver has to judge speed, distance, timing, and space all at once. A small mistake can put the car directly in front of fast-moving traffic. Daniel Stark explains that unprotected left turns are especially dangerous because drivers may misjudge the speed of oncoming traffic, creep too far forward, or become impatient and try to beat traffic. Other legal summaries of T-bone crashes say the same pattern is common when a driver turns left without waiting for a safe gap. (Daniel Stark, 2026; DCM&D Law, 2026).

Common causes include:

  • poor judgment of distance or speed
  • rushing through a gap that is too small
  • creeping too far into the lane
  • poor visibility
  • distraction
  • trying to clear the median opening too quickly
  • assuming the oncoming driver will slow down or stop (Daniel Stark, 2026; TopDog Law, 2025).

Who Is Usually at Fault

In most of these crashes, the left-turning driver is usually at fault because that driver had the duty to wait until the way was clear. Texas Transportation Code Section 545.152 places that duty directly on the left-turning driver. Legal explainers on left-turn and T-bone crashes also consistently say that a driver who turns into oncoming traffic is usually responsible for the collision. (Texas Legislature, 2025; TopDog Law, 2025; DCM&D Law, 2026).

However, “usually” does not mean “always.” A fault can become shared if the oncoming driver was speeding, distracted, impaired, or ran a red light. That is why investigators often review witness statements, traffic signals, vehicle damage, and final vehicle positions before reaching a full conclusion. (TopDog Law, 2025; Uptown Injury, 2025).

Common Injury Patterns in a T-Bone Crash

Side-impact crashes can be serious because there is less space between the occupant and the point of impact. NCBI’s StatPearls notes that frontal and near-side collisions commonly create head, neck, chest, and abdominal injuries. Research on side collisions also shows that injury risk is often higher than in frontal crashes because there is less vehicle structure to absorb the impact on the struck side. (Toney-Butler & Varacallo, 2023; Frampton et al., 1998).

After a failure-to-yield left-turn crash, common injuries may include:

  • whiplash and neck strain
  • shoulder pain and reduced motion
  • rib and chest wall pain
  • low back pain
  • hip or pelvic pain
  • headaches
  • numbness or tingling
  • bruising and soft tissue injury
  • disc irritation or nerve-related symptoms
  • in more serious cases, abdominal injury, fracture, or concussion-related symptoms (Toney-Butler & Varacallo, 2023; Yadla et al., 2008).

Whiplash is one of the most common injuries after a crash because the head and neck are suddenly forced to move. The Mayo Clinic explains that whiplash often causes neck pain, stiffness, headaches, and limited range of motion. A broader review of whiplash-associated disorders also lists arm pain, paresthesias, headache, dizziness, and concentration problems among the common symptoms. (Mayo Clinic, 2024a; Yadla et al., 2008).

Why Some Symptoms Do Not Show Up Right Away

One of the biggest mistakes people make after a side-impact crash is assuming they are fine because pain has not started yet. ChiroMed’s own MVA education page notes that whiplash symptoms may not show immediately because adrenaline can mask pain at first, with discomfort sometimes appearing within 24 hours. Research on late whiplash patterns also reports that headache and neck pain can begin hours after impact rather than right away. (ChiroMed, 2026; Astrup et al., 2022).

That is why patients should pay attention to delayed signs such as:

  • neck stiffness
  • headaches
  • dizziness
  • shoulder tightness
  • low back pain
  • numbness or tingling
  • reduced range of motion
  • pain that worsens the next day or over the next week (ChiroMed, 2026; Mayo Clinic, 2024b).

How ChiroMed Approaches Recovery After a T-Bone Accident

ChiroMed presents auto-injury care as more than just basic symptom relief. Its materials describe a team-based model that combines chiropractic care with rehabilitation and broader clinical support. On the ChiroMed site, Dr. Alex Jimenez is described as a dual-licensed provider who leads a multidisciplinary team focused on holistic, patient-centered care for whiplash, neck and back pain, complex personal injuries, and severe auto accident rehabilitation. ChiroMed also explains that its nurse practitioners help bridge conventional and alternative medicine by working with chiropractors and other specialists to build comprehensive plans. (ChiroMed, 2026a; ChiroMed, 2026b).

For a patient hurt in a failure-to-yield left-turn crash, an integrative plan may include:

  • chiropractic adjustments or mobilization to improve joint movement
  • soft tissue work or massage to calm muscle tension
  • rehabilitation exercises to rebuild strength and coordination
  • posture and movement retraining
  • imaging or deeper clinical evaluation when symptoms suggest a more complex injury
  • supportive therapies such as acupuncture, depending on the case (ChiroMed, 2026a; ChiroMed, 2026c).

ChiroMed’s MVA page states that chiropractic care after collisions can help reduce joint inflammation, improve mobility, and support long-term recovery through spinal adjustments, soft-tissue therapies, rehabilitation exercises, and individualized care plans. Its broader injury-recovery content also highlights detailed documentation and integrated treatment when legal and insurance issues are part of the case. (ChiroMed, 2026c; ChiroMed, 2026d).

Why Physical Rehabilitation Matters

Good recovery after a T-bone crash is not just about getting the pain to calm down. It is also about restoring motion, stability, endurance, and safe daily function. Mayo Clinic says active physical therapy programs can reduce pain and disability in whiplash cases, and those programs often include range-of-motion work, cervical strengthening, coordination training, and functional exercises. Mayo also notes that simple movement exercises can help patients return to normal activities. (Mayo Clinic, 2022; Mayo Clinic, 2024b).

That rehab focus fits with ChiroMed’s site style and services. The clinic emphasizes rehabilitation as part of its integrated care model, which is important for patients who need more than a quick adjustment. A person recovering from a side-impact crash may need a staged plan that starts with pain control, then moves into mobility work, then into strengthening and functional recovery. (ChiroMed, 2026a; ChiroMed, 2026c).

Dr. Alex Jimenez’s Dual-Scope Perspective

One of the strongest site-specific angles for ChiroMed is Dr. Alex Jimenez’s dual-scope background. ChiroMed describes him as both a chiropractic doctor and an advanced practice nurse practitioner, and its injury pages present the combined skill set as useful for evaluating complicated motor vehicle cases. ChiroMed also highlights medical precision, chiropractic expertise, and documentation support in injury-related care. (ChiroMed, 2026a; ChiroMed, 2026e).

For patients injured in a failure-to-yield left-turn crash, that dual perspective can be valuable because side-impact collisions may involve more than one body system at once. A patient may have neck strain, nerve symptoms, shoulder dysfunction, low back pain, and soft-tissue injury, all from the same event. A combined medical and chiropractic perspective can help link crash mechanics to the patient’s symptoms and recovery needs. (Toney-Butler & Varacallo, 2023; ChiroMed, 2026e).

The Bottom Line

A “Failure to Yield Left Turn” crash is usually both a legal and physical event. Legally, it is most often a failure-to-yield problem on the part of the turning driver. Physically, it is often a T-bone or side-impact collision that can create neck, back, shoulder, rib, pelvic, and nerve-related injuries. Because symptoms can be delayed and injury patterns can be complex, patients often benefit from a thorough, integrative recovery plan. For a ChiroMed audience, that means looking beyond short-term pain and focusing on accurate diagnosis, whole-body treatment, rehabilitation, and long-term return to function. (Texas Legislature, 2025; Mayo Clinic, 2024b; ChiroMed, 2026a).

References

The Gut-Immune System and Hormones Role in Overall Wellness

Dive into the world of the gut-immune system and hormones and their crucial role in supporting immune health and overall wellness.

Abstract

I wrote this educational post to share how I moved from medication stacks to a systems-biology model that begins in the gut and extends through the immune, endocrine, and nervous systems. Drawing on modern methods such as metagenomic sequencing, metabolomics, intestinal permeability assays, and autonomic measures (e.g., HRV), I explain how dysbiosis, leaky gut, and LPS-driven inflammation disrupt estrogen metabolism, thyroid hormone conversion, insulin sensitivity, and mood. You will learn why supporting the estrobolome, optimizing vitamin D3–K2–A cofactors, and balancing iodine–selenium for thyroid are pivotal. I discuss practical protocols using diet, prebiotics, probiotics, butyrate support, DIM/I3C, calcium D-glucarate, glutamine, methylation cofactors, and, when appropriate, shilajit to sustain free testosterone. I also show where integrative chiropractic care fits: improving vagal tone, diaphragmatic mechanics, and autonomic balance to normalize motility, lower inflammation, and help good plans work. Throughout, I reference my clinical observations from ChiroMed and the latest findings from leading researchers, so you can see the rationale behind each step and apply this roadmap safely and effectively.

Why I Now Start With The Gut, Then Layer Hormones, Thyroid, And Structure

I trained in conventional models and spent years optimizing hormones and metabolism. I prescribed intensively, studied incretins and GLP-1, and did everything I could to improve diabetes and endocrine care. Many patients improved—but too many plateaued. The turning point came when I consistently addressed gut integrity and the neuroimmune axis first: patients’ medication burdens decreased, weight and energy normalized, and mood and cycles stabilized. When I dug deeper into the 25–30% who still struggled, I found a common thread: dysbiosis, intestinal permeability, and autonomic dysregulation blocked progress.
My clinical lesson: persistent symptoms usually reflect a convergence of microbiome imbalance, barrier dysfunction, immune activation, autonomic imbalance, and environmental mismatch. These systems converge in the gut. That’s why my care integrates functional nutrition, targeted supplementation, hormone and thyroid optimization, and integrative chiropractic to restore nervous system balance and biomechanics. Across my clinical work at ChiroMed and case reflections I share on LinkedIn, a gut-first framework reliably transforms outcomes (Jimenez, n.d.-a; Jimenez, n.d.-b).

The Gut Microbiome As A Neuroendocrine And Immune Control Center

The microbiome is a living organ system. In a healthy state, it:

  • Produces short-chain fatty acids (SCFAs)—especially butyrate, propionate, and acetate—that fuel colonocytes, tighten epithelial tight junctions, and tame inflammation (Canfora et al., 2019).
  • Trains GALT and regulatory T cells (Tregs), fostering immune tolerance (Turnbaugh & Gordon, 2019).
  • Maintains barrier integrity, preventing lipopolysaccharide (LPS) translocation and downstream TLR4–NF-κB signaling (Camilleri, 2019).
  • Modulates neurotransmitters and the HPA axis, influencing serotonin via enterochromaffin cells and stress resilience (Cryan & Dinan, 2015).
  • Shapes hormone metabolism, including the estrobolome, insulin sensitivity, and thyroid conversion.

When dysbiosis develops, we see reduced butyrate-producing bacteria, an excess of pathobionts, and elevated beta-glucuronidase—an enzyme that can deconjugate estrogens and promote estrogen recirculation. Clinically, this presents as bloating, irregular stools, acne, brain fog, fatigue, weight plateaus, and hormone therapy that “doesn’t stick.” Mechanistically, increased LPS fuels systemic inflammation and insulin resistance; reduced SCFAs loosen junctions and weaken mucosal defense; and neuroendocrine signaling drifts toward anxiety, low mood, and poor sleep.

Intestinal Permeability, Zonulin, and the Inflammation–Endocrine Loop

“Leaky gut” is a measurable phenomenon. Tight junctions—regulated by proteins like claudin, occludin, and zonulin—hold epithelial cells together. When zonulin rises in response to gluten, infections, dysbiosis, or stress, the junctions loosen, allowing dietary antigens and microbial fragments to enter the circulation (Fasano, 2012). The consequences:

  • Immune activation: Elevated TNF-α and IL-6 amplify systemic inflammation.
  • Endocrine disruption: Cytokines increase cortisol and insulin, blunt T4→T3 conversion, and alter sex hormone balance.
  • Metabolic effects: Raised insulin and cortisol promote fat storage and alter appetite circuits.

Repeated postprandial endotoxemia (LPS spikes after meals) is well documented with high-fat, ultra-processed diets, fueling insulin resistance and barrier erosion (Cani et al., 2007). In my practice, I routinely see elevated zonulin, LPS-binding protein, low SCFAs, and high beta-glucuronidase in stressed, symptomatic patients. When we seal the barrier and calm LPS, endocrine therapies begin to work the way we expect.

The Estrobolome, Beta-Glucuronidase, And Estrogen Recirculation

The estrobolome—the gut microbial genes that metabolize estrogens—determines whether estrogens are excreted or recirculated. In the liver, estrogens are conjugated (often glucuronidated) and excreted via bile. If the microbiome produces excess beta-glucuronidase, it deconjugates estrogens in the intestine, thereby enabling reabsorption through the intestinal wall (Plottel & Blaser, 2011; Flores et al., 2012). Add constipation, and you compound recirculation. Clinically, I see:

  • Worsened PMS, mastalgia, fibrocystic changes, and heavier cycles.
  • Frustration with hormone therapy due to increased metabolites returning to circulation.
  • Mood variability and breast density changes when the 2-OH:16-OH balance is unfavorable.

Supporting fiber, calcium D-glucarate, DIM/I3C, methylation cofactors, bile flow, and daily bowel movements can reverse this loop.

PCOS, Endometriosis, And The Gut–Hormone Axis

  • PCOS: Dysbiosis raises LPS and zonulin, driving inflammation and insulin resistance, which increases ovarian theca cell androgen production. Result: hyperandrogenism, anovulation, acne, and metabolic risk (Qi et al., 2022). When I rebuild the barrier, raise SCFAs, and add resistance training with targeted nutrition, fasting insulin drops, cycles stabilize, and skin clears.
  • Endometriosis: Elevated beta-glucuronidase and permeability raise circulating estrogen and pelvic inflammation. Estrogen metabolism favors 2-hydroxylation over proliferative or genotoxic pathways when supported with DIM, I3C, methylation, and glucuronidation aids (Yager & Davidson, 2006; Taylor et al., 2020). My patients often report lighter cycles and reduced pain when transit improves, and recirculation decreases.

Thyroid Conversion, Iodine–Selenium Synergy, and Hashimoto’s

Thyroid function hinges on substrate availability and redox safety:

  • Iodine is essential for T4/T3 synthesis, but it must be managed carefully—especially in autoimmune thyroiditis.
  • Selenium-dependent enzymes (glutathione peroxidases, deiodinases) detoxify H2O2 used by TPO and convert T4 to T3. Low selenium levels increase oxidative stress and can heighten antibody activity; supplementation can lower TPO antibody levels in some patients (Gärtner et al., 2002).

In Hashimoto’s, dysbiosis and intestinal permeability elevate cytokine levels, impairing T4→T3 conversion and nutrient absorption (Caturegli et al., 2014). Correcting the microbiome, supporting the barrier, and using vitamin D3–K2–A with magnesium (for vitamin D metabolism) improves immune tolerance and thyroid status. In my clinic, combining selenium (100–200 mcg/day) with gut repair and stress modulation often stabilizes symptoms and antibody trends.

Vitamin D3, K2, Magnesium, And Vitamin A: Directing Calcium And Calming Immunity

Many patients take vitamin D3 without cofactors. For safety and efficacy:

  • Magnesium supports the enzymes that convert D into its active forms.
  • Vitamin K2 (MK-7) activates osteocalcin and matrix Gla protein (MGP), directing calcium to bones and away from arteries (Beulens et al., 2013).
  • Vitamin A (retinol) works synergistically with D and K to balance bone remodeling and epithelial integrity.

I generally target 25(OH)D at 50–70 ng/mL, titrating based on labs, with D3 taken with fat and magnesium, plus K2 (and judicious vitamin A when indicated) (Pilz et al., 2019; Mitchell et al., 2022). Clinically, this reduces musculoskeletal aches, improves mood and immune balance, and safeguards vascular health during endocrine optimization.

Akkermansia, SCFAs, And Metabolic Flexibility

I pay close attention to Akkermansia muciniphila, a mucin-degrading bacterium associated with stronger mucus layers and better metabolic profiles. Low levels of Akkermansia correlate with barrier fragility and weight-loss resistance (Everard & Cani, 2013). When I support mucosal nutrition (polyphenols from berries and pomegranates; prebiotic fibers; omega-3s), Akkermansia often rebounds. When combined with fiber-induced SCFAs, patients regain insulin sensitivity, see improved fasting glucose, and break stubborn weight plateaus.

Evidence-Based Tools That Inform Personalization

Modern research methods help move from guesswork to precision:

  • Metagenomics identifies microbial composition and functional genes (e.g., SCFA producers, Enterobacteriaceae) to target interventions (Turnbaugh & Gordon, 2019).
  • Metabolomics measures functional outputs—such as SCFAs, bile acids, and indoles—to gauge progress.
  • Permeability assays (e.g., serum zonulin, lactulose/mannitol) and markers like LPS-binding protein quantify barrier function (Camilleri, 2019).
  • Neurogastroenterology and HRV assessments tailor autonomic and motility interventions (Tracey, 2002).

This data-driven approach, combined with clinical observation, improves accuracy, safety, and recovery speed.

Integrative Chiropractic Care: Why Structure And Autonomics Matter

As a chiropractor and nurse practitioner, I witness how biomechanics and the autonomic nervous system shape gut and endocrine function:

  • Vagal tone: Gentle cervical work, rib mechanics, diaphragmatic release, and paced breathing increase parasympathetic output, improving gastric accommodation and GI motility, while reducing visceral hypersensitivity.
  • Spinal and pelvic mechanics: Thoracolumbar and sacral segments modulate sympathetic and parasympathetic outflow to the GI tract; restoring mobility reduces nociceptive drive and systemic cytokine levels.
  • Movement prescriptions: Rhythmic aerobic work and resistance training improve insulin sensitivity and myokine profiles, enhancing metabolic resilience.

In my practice, adding HRV-guided breathing, diaphragmatic training, and targeted adjustments accelerates gut recovery and stabilizes mood and sleep. Structural integration is not optional; it is central to steady autonomic balance and endocrine stability (Tracey, 2002; Cryan & Dinan, 2015; Jimenez, n.d.-a; Jimenez, n.d.-b).

DIM, I3C, And Safer Estrogen Metabolism

Diindolylmethane (DIM) and indole-3-carbinol (I3C) help steer estrogen toward the 2-hydroxy (2-OH) pathway, away from 4-OH quinone-prone and 16-OH proliferative metabolites. Mechanisms include modulation of CYP enzymes and support of COMT-mediated methylation (Bradlow, 2019; Kabat et al., 2006). In practice:

  • Women: DIM 100–150 mg/day, titrating up to 300 mg/day when PMS, mastalgia, or estrogen dominance persists.
  • Men: DIM 300 mg/day, up to 600 mg/day in select prostate risk scenarios while monitoring.

I pair DIM with methylated B vitamins and sulforaphane (Nrf2 activation) to ensure conjugation and detox pathways keep pace (Singh et al., 2011). Clinically, patients report improved breast density profiles and better tolerance to HRT when DIM is maintained.

Calcium D-Glucarate, Methylation, Bile Flow, And Daily Excretion

To reduce beta-glucuronidase reactivation and enterohepatic recirculation, I use:

  • Calcium D-glucarate to support glucuronidation.
  • Methylation support (methylfolate, methylcobalamin, B6/P5P, TMG) to detoxify catechol estrogens and maintain COMT function—especially when 4-OH is elevated.
  • Bile flow support with bitters (e.g., gentian, dandelion) and hydration to carry conjugated estrogens into the intestine.
  • Transit optimization with fiber and gentle movement. Constipation is a nonstarter—daily bowel movements are mandatory for estrogen safety.

This Phase I–II–III strategy ensures metabolites are formed safely (Phase I), conjugated (Phase II), and eliminated (Phase III).

Glutamine, Zinc Carnosine, And Mucosal Repair

When permeability is high or mucosal stress is severe, I deploy:

  • L-glutamine to fuel enterocytes and bolster tight junction protein expression.
  • Zinc carnosine to stabilize mucosal surfaces and reduce oxidative stress (Ueda et al., 2007).
  • Omega-3s and demulcents as needed.

Patients often experience reduced bloating, better stool quality, and calmer skin when mucosal repair is prioritized.

Shilajit And Free Testosterone: Sustaining Benefits Across Pellet Cycles

Late in testosterone pellet cycles, many patients report symptom drift despite acceptable total testosterone. The culprit is often a decline in free testosterone, the bioavailable fraction that drives receptor signaling. Purified shilajit has shown significant increases in both total and free testosterone (e.g., ~31% and ~51% respectively at 250 mg twice daily in a randomized, placebo-controlled trial), likely via fulvic acid–mediated mitochondrial and transport effects (Pandit et al., 2016). In my clinic:
Adding purified shilajit during the latter half of a pellet cycle stabilizes free testosterone without pushing total levels into side-effect territory.
Patients report steadier energy, drive, and recovery.
I integrate shilajit into a comprehensive HRT support stack (DIM, methylated B’s, sulforaphane, CoQ10) to support balanced metabolism and oxidative protection.
For women with PCOS or androgen sensitivity, I avoid raising androgens and instead emphasize estrogen detoxification and an insulin-sensitizing lifestyle.

Practical, Stepwise Clinical Plan

Here is how I typically structure care:

  • Phase 1: Calm the fire
    • Remove ultra-processed foods, dyes, and excess alcohol.
    • Establish hydration, protein adequacy, and high-fiber, polyphenol-rich meals.
    • Start multi-strain probiotics, prebiotics (inulin, FOS, GOS, resistant starch), and L-glutamine; add zinc carnosine if mucosal stress is evident.
    • Begin paced breathing (≈6 breaths/min), humming or gargling, and chiropractic sessions to downshift sympathetic tone.
    • Target sleep: a consistent schedule, a cool, dark room, and morning light.
  • Phase 2: Restore and rebalance
    • Add DIM/I3C based on symptoms or metabolite data; support methylation (methylfolate, B12, B6, TMG).
    • Introduce calcium D-glucarate for glucuronidation; enhance transit with diverse fibers.
    • Train with progressive resistance (3x/week) and zone 2 cardio (2x/week).
    • Ensure daily bowel movements and support bile flow with bitters.
  • Phase 3: Optimize and personalize
    • Reassess stool metrics (zonulin, SCFAs, beta-glucuronidase, Akkermansia) and hormone metabolites.
    • Correct nutrient deficits (vitamin D, magnesium, omega-3s, iron, zinc).
    • Support Akkermansia with polyphenols and mucin-feeding fibers; maintain D3–K2–A for calcium handling and immune balance.
    • For pellet-based HRT, consider shilajit to sustain free testosterone; for PCOS or estrogen dominance, lean on detox supports without increasing androgens.
    • Maintain integrative chiropractic care to reinforce autonomic balance and movement quality.

Modulating Women’s Hormones- Video

Clinical Observations From My Practice

From my work at ChiroMed and professional updates I share on LinkedIn:

  • Patients with “great labs” but persistent symptoms often harbor dysbiosis, increased permeability, or elevated beta-glucuronidase—addressing these unlocks progress (Jimenez, n.d.-a; Jimenez, n.d.-b).
  • Pairing resistance training with gut repair stabilizes cycles and insulin in PCOS; skin and mood follow.
  • Akkermansia repletion tracks with breaking weight-loss plateaus, even after GLP-1 use.
  • Integrative chiropractic care improves adherence and resilience—when pain and sleep improve, nutrition and movement protocols stick, accelerating gut and hormone balance.

Why These Techniques Work: Physiology-First Reasoning

  • Prebiotics and fiber → raise SCFAs, especially butyrate, tightening junctions and lowering inflammatory signaling (Canfora et al., 2019). This reduces LPS leakage and stabilizes endocrine pathways.
  • Synbiotics (probiotics + prebiotics) → re-seed commensals and feed them, improving stool form, immune markers, and motility in IBS and dysbiosis.
  • Glutamine and zinc carnosine → restore epithelial energy and mucosal structure, lowering antigen translocation (Ueda et al., 2007).
  • DIM/I3C → steer estrogen toward 2-OH and away from 4-OH/16-OH, lowering quinone burden and proliferative signaling (Bradlow, 2019; Kabat et al., 2006).
  • Methylation support → completes detox of catechol estrogens and protects DNA via COMT and related pathways.
  • Calcium D-glucarate → promotes glucuronidation and reduces beta-glucuronidase-driven recirculation.
  • D3–K2–A with magnesium → improves immune modulation and calcium trafficking, protecting bone and vasculature (Beulens et al., 2013; Pilz et al., 2019; Mitchell et al., 2022).
  • Iodine with selenium → restores thyroid hormone synthesis while protecting against H2O2-driven oxidative damage; supports deiodinases (Gärtner et al., 2002; Zimmermann, 2003).
  • Shilajit → raises free testosterone and supports mitochondrial function, smoothing symptom curves across pellet cycles (Pandit et al., 2016).
  • Chiropractic-informed autonomic care → increases vagal tone and reduces nociception, lowering cytokines and improving motility, digestion, and sleep (Tracey, 2002; Cryan & Dinan, 2015).

Putting It All Together: A Gut-First, Whole-Person Strategy

When we respect the body’s systems biology, we see why a gut-first strategy with autonomic balance makes hormones and thyroid therapies work predictably. By:

  • Sealing the barrier and raising SCFAs,
  • Lowering LPS and cytokines,
  • Steering estrogen metabolism toward safer pathways with DIM/I3C and ensuring excretion with calcium D-glucarate, fiber, and bile flow,
  • Optimizing vitamin D3–K2–A with magnesium and carefully integrating iodine–selenium for thyroid,
  • Supporting bioavailable androgens with shilajit when appropriate,
  • And integrating chiropractic care to normalize autonomic tone and movement.

We consistently move patients from symptom management to durable health. This approach is practical, measurable, and aligned with modern, evidence-based methods. In my experience, it is also the fastest, safest way to feel well and stay well.

References


SEO tags: gut health, dysbiosis, intestinal permeability, LPS, SCFAs, estrobolome, beta-glucuronidase, estrogen metabolism, DIM, I3C, calcium D-glucarate, vitamin D3, vitamin K2, vitamin A, iodine, selenium, Hashimoto’s, thyroid conversion, Akkermansia muciniphila, shilajit, free testosterone, HRT pellets, integrative chiropractic care, vagal tone, HRV, functional medicine, microbiome sequencing, metabolomics, NF-κB, TLR4, COMT, Nrf2

Hormone Optimization Techniques For Thyriod Health

Achieve optimal thyroid health through hormone optimization and support your body’s natural balance and energy.

Abstract

In this educational post, I will explore the nuanced and highly individualized world of hormone optimization, moving beyond rigid, population-based “normal” ranges to focus on patient-centered, evidence-based outcomes. We will delve into the physiological importance of key hormones like testosterone, thyroid hormones (T4 and T3), and progesterone, and discuss the complex considerations surrounding estrogen therapy, particularly for patients with a history of cancer. My goal is to illuminate the rationale behind a functional and integrative approach, emphasizing that true health is about how a patient feels and functions, supported by data, not just about achieving a specific number on a lab report. We will discuss why a low testosterone level, even if the patient feels “normal,” poses significant long-term health risks, including increased all-cause mortality, type 2 diabetes, and Alzheimer’s disease. Furthermore, I’ll explain how integrative chiropractic care, by addressing the body’s structural and neurological integrity, provides a foundational pillar of support for these hormonal therapies, enhancing overall physiological function and patient well-being. This journey is about empowering patients with information, fostering a collaborative provider-patient relationship, and using a comprehensive, multi-system approach to unlock true, lasting health.

The Fallacy of “Normal”: Redefining Hormone Lab Ranges

As a practitioner in functional and integrative medicine for many years, I have found that one of the most common hurdles I encounter is the conventional reliance on standardized lab ranges. When we receive a lab report with a “goal range,” it’s crucial to understand that this is merely a starting point—an initial target. It is not a one-size-fits-all destination for every individual. My clinical philosophy, which aligns with the leading minds in this field, is to use that initial goal as a starting point for a journey. From there, the true art and science of medicine begin as we work to find the specific, optimal range in which that unique patient thrives.
I’ve had countless conversations about this. For example, a man might have a total testosterone level of 300 ng/dL. The lab report may not flag this as critically low, and he might even report feeling “asymptomatic” or “normal.” This is where a deeper, evidence-based understanding is vital.

  • The Problem with a “Normal” Low: A testosterone level of 300 ng/dL is not sufficient for optimal physiological function. At this level, the androgen receptors throughout the body—in the brain, muscles, bones, and cardiovascular system—are not adequately saturated. This undersaturation is a major risk factor.
  • Long-Term Health Risks: Leading researchers like Dr. Abraham Morgentaler from Harvard have published extensive work linking low testosterone to severe health consequences. Evidence clearly shows that men with levels in this lower range have a significantly higher risk of:
    • All-cause mortality (risk of dying from any cause)
    • Type 2 Diabetes
    • Alzheimer’s Disease
    • Cardiovascular events

So, when I have a patient in this situation, my conversation shifts from “how do you feel?” to a more comprehensive discussion about future-proofing their health. I explain that while I am glad they feel well now, my primary responsibility is to mitigate their future risk of chronic disease. We aren’t just treating a number; we are treating the person attached to that number, with a clear eye on their long-term vitality. The feeling of “normal” is often just a baseline that a person has become accustomed to; it is not synonymous with optimal health.

The Interplay of Hormones: A Symphony of Systems

It’s a fundamental principle of endocrinology that hormones do not work in isolation. They function as a complex, interconnected orchestra. If one instrument is out of tune, the entire symphony is affected. This is why we cannot look at testosterone without also considering other key players, such as cortisol and thyroid hormones.
Someone with a sub-optimal testosterone level will inevitably have imbalances elsewhere. Perhaps their sense of “normal” is their body’s maladaptive state. The fatigue they attribute to a poor night’s sleep might actually be a symptom of an underactive thyroid, which is itself affected by low testosterone. This is where a thorough, functional workup becomes indispensable. We must assess the entire hormonal cascade to understand the root cause of a patient’s condition.

Cracking The Low Thyroid Code- Video

The Role of Integrative Chiropractic Care

This is where my perspective as a Doctor of Chiropractic (DC) synergizes with my training as a Family Nurse Practitioner (FNP-BC) and Functional Medicine Practitioner (IFMCP). The nervous system is the master conductor of the endocrine orchestra. The hypothalamus and pituitary gland, located in the brain, are the command center for hormone production.

  • Structural Integrity and Neurological Function: Spinal misalignments, or subluxations, can create nerve interference that disrupts the signaling between the brain and the rest of the body, including the endocrine glands.
  • Stress and the HPA Axis: Chiropractic adjustments have been shown to modulate the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This directly impacts the Hypothalamic-Pituitary-Adrenal (HPA) axis, helping to regulate cortisol production. Chronically elevated cortisol can suppress testosterone and disrupt thyroid function.

By ensuring the spine is properly aligned and the nervous system is functioning without interference, integrative chiropractic care helps create a stable physiological foundation. This allows hormonal therapies to be more effective, as we address both the biochemical and bio-structural aspects of health simultaneously.

Navigating Complex Cases: Hormone Therapy After Diagnosis

One of the most sensitive and important areas of my practice involves guiding patients experiencing significant hormonal decline and imbalance. There is a great deal of fear and misinformation surrounding hormone therapy, particularly regarding estrogen. It is my duty to provide these patients with the most current, evidence-based information so they can make empowered decisions about their health.

Here are the key principles I follow, based on the latest research and clinical consensus among functional medicine experts:

  • Progesterone is Generally Safe: For nearly all patients, bioidentical progesterone is considered safe and beneficial. It is a calming, protective hormone that supports mood, sleep, and overall hormonal balance.
  • Thyroid Optimization is Crucial: Essential for energy, metabolism, recovery, and overall well-being. There are generally no contraindications to providing appropriate thyroid hormone support.

Patients experiencing hypothyroidism often suffer from profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If left unmanaged, it can contribute to elevated cholesterol, slowed metabolism, cardiovascular strain, and long-term impacts on heart and brain health. In contrast, hyperthyroidism may present with symptoms such as unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. Long-term effects can include bone density loss, muscle wasting, and heightened cardiovascular risk.

  • Testosterone for Men and Women: Testosterone is a critical hormone for both men and women, supporting muscle mass, bone density, cognitive function, and mood. It can be safely administered with proper monitoring.
  • Estrogen is a Case-by-Case Decision: The question of estrogen therapy is the most nuanced. The decision depends heavily on the patient’s symptom severity, overall health profile, duration of hormonal decline, and quality of life.

Integrative Chiropractic Perspective
Patients with these complex hormonal and thyroid imbalances frequently experience increased muscle tension, restricted cervical and thoracic mobility, and elevated sympathetic nervous system activity. Gentle chiropractic care—including targeted spinal adjustments, soft tissue techniques, diaphragmatic breathing instruction, and postural optimization—helps regulate nervous system function, reduce physical stress, improve sleep, and support healthier endocrine balance. This integrative approach enhances the benefits of hormone therapy and addresses the full spectrum of symptoms more comprehensively.

An Individualized Approach to Estrogen

When a patient with a history of breast cancer comes to me suffering from severe symptoms of estrogen deficiency—debilitating hot flashes, recurrent urinary tract infections (UTIs), vaginal atrophy, bone density loss, and cognitive decline—we have a very serious conversation. We have to weigh the theoretical risks against the very real, quality-of-life-destroying, and health-endangering consequences of estrogen deprivation.
Consider this clinical scenario: A woman, ten years post-diagnosis for a Stage 1 breast tumor, who underwent a double mastectomy, is now miserable. Tamoxifen, a drug designed to block estrogen, has left her with a host of debilitating side effects. Her oncologist offers no alternatives. In this case, she came to me seeking to reclaim her life. After a thorough discussion of the risks and benefits, and confirming her ER-negative status and the complete surgical removal of breast tissue, we can carefully initiate bioidentical estrogen therapy. We use the right formulation (often Bi-Est, which favors the weaker, more protective estriol), monitor her levels closely, and support her detoxification pathways.
What is the alternative? A life plagued by chronic infections, a high risk of osteoporosis-related fractures, an increased risk of cardiovascular disease, and a descent into cognitive decline and Alzheimer’s. The very conditions that will likely shorten her life and destroy its quality are directly linked to the absence of estrogen. Leading research, such as the comprehensive review by Sarrel et al. (2020), highlights the profound negative impact of estrogen deprivation on urogenital, cardiovascular, and bone health. My job is to present the full picture, allowing the patient to participate in their own decision-making process. This right is too often taken away in conventional oncology settings.

The Importance of Thyroid Hormone T3, Especially During Pregnancy

Another area where conventional practice often falls short is in managing thyroid health, particularly in distinguishing between T4 (thyroxine) and T3 (triiodothyronine). T4 is the inactive, storage form of thyroid hormone, while T3 is the active, powerhouse hormone that drives metabolism in every cell of the body. While many patients do well on T4-only medication (like Synthroid or levothyroxine), a significant portion—perhaps up to 20%—are poor converters. Their bodies cannot efficiently turn T4 into the usable T3. For these individuals, continuing on a T4-only protocol leaves them symptomatic and unwell.
This becomes critically important during pregnancy.

  • Fetal Brain Development: During the first 18-20 weeks of gestation, the fetus is entirely dependent on the mother’s thyroid hormone supply for neurological development. Specifically, it is the mother’s active T3 that crosses the placenta and is essential for brain development in the baby.
  • Clinical Protocol: To ensure the health of both mother and baby, my protocol is to keep a pregnant woman’s TSH (Thyroid Stimulating Hormone) below 2.5, and often closer to 1.5, during the first trimester. I ensure she has adequate T3 available. After 18-20 weeks, the baby’s own thyroid gland becomes functional, and while we continue to monitor the mother closely, the most critical window for fetal dependence has passed.

Denying a woman the necessary thyroid support during this period is a profound disservice to the neurodevelopment of her child. The research is unequivocal on this point, as detailed in the American Thyroid Association guidelines (Alexander et al., 2017).

The Power of Patient Empowerment and Building Trust

Ultimately, my role is to serve as an educator and a partner. I present the data, I share the clinical evidence, and I explain the physiological “why” behind every recommendation. Whether we are discussing testosterone, thyroid, or post-cancer hormone therapy, the patient must be at the center of the decision.
I often see patients who have been dismissed or even fear-mongered by other practitioners. They come to me frustrated and hopeless. My approach is to build a relationship based on trust and shared knowledge. I might say, “What you have been doing for the last five years hasn’t worked. Let’s try something different for 12 weeks. We will monitor you closely. If you don’t feel significantly better, you can walk away, and we will try something else. But let’s give your body the tools it needs to heal.”
This collaborative approach is transformative. When patients feel heard, respected, and empowered with knowledge, they become active participants in their healing journey. Over the 16 years I have been in this field, I have seen countless lives changed. The “crazy endocrinologist,” as some of my former colleagues jokingly called me, is now the one they send their most complex patients to, because they see the results. They see patients not just surviving, but truly thriving. And that is the ultimate goal of everything we do.


References

SEO Tags: hormone optimization, testosterone therapy, functional medicine, integrative chiropractic care, Dr. Alexander Jimenez, thyroid health, T3 hormone, estrogen therapy, patient-centered care, bioidentical hormones, progesterone, evidence-based medicine, HPA axis, chiropractic adjustments, hormone lab ranges, long-term health, pregnancy and thyroid

Gut Health and Hormone Balance Treatment

Gut Health and Hormone Balance Treatment

Gut Health and Hormone Balance Treatment

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through the science and practice of optimizing hormones by treating the gut–liver–hormone axis and reinforcing micronutrient and mitochondrial foundations. I explain how dysbiosis, intestinal permeability, and microbial enzymes like beta-glucuronidase reshape estrogen metabolism and influence conditions such as PCOS, endometriosis, and autoimmunity, and how lipopolysaccharide (LPS) and short-chain fatty acids (SCFAs) affect insulin sensitivity, mood, and inflammation. I translate current research on vitamin D, K2, iodine, selenium, methylated B vitamins, DIM, and shilajit into clinic-ready protocols, and I show where integrative chiropractic care fits by supporting vagal tone, motility, neuromusculoskeletal dynamics, and autonomic balance. You will find practical frameworks, dosing concepts, lab-monitoring advice, and rationale for each intervention, with citations to leading researchers.

Why Hormones Are Microbiome-Dependent: The Gut–Liver–Hormone Axis

When I first connected hormone symptoms to gut physiology, I saw a pattern: many “hormone” problems began as microbiome and barrier problems. The gut microbiome—a complex community of bacteria, viruses, fungi, and archaea—regulates digestion, immune tolerance, barrier integrity, and the enterohepatic circulation that clears estrogens. From the earliest studies linking metabolic endotoxemia to insulin resistance, it has become clear that LPS-driven inflammation can disrupt cardiometabolic and reproductive health (Cani et al., 2007).

  • When the microbiome is balanced, commensals generate SCFAs (notably butyrate) that nourish colonocytes, tighten junctions, and reduce inflammatory signaling.
  • When dysbiosis develops, beta-glucuronidase-producing taxa expand, and LPS permeates, amplifying NF-κB cytokine cascades that alter hormone receptors, hepatic detoxification, and insulin signaling (Fasano, 2012; Slyepchenko et al., 2017).

Clinically, if you manage estrogen symptoms, insulin resistance, or autoimmune patterns, you are managing the microbiome—whether you realize it or not.

Dysbiosis and Leaky Gut Explained: Distinct Problems that Reinforce Each Other

Two related but distinct issues commonly coexist:

  • Dysbiosis: A shift away from beneficial microbes, with loss of diversity and expansion of pathobionts. Consequences include increased LPS, altered bile acid signaling, and elevated beta-glucuronidase.
  • Leaky gut (increased intestinal permeability): Disruption of tight junction proteins (occludin, claudins, ZO-1) allows antigens and endotoxins to enter circulation, thereby increasing systemic inflammation and immune activation (Fasano, 2012).

Why that matters for hormones:

  • LPS activates TLR4–NF-κB, increasing TNF-α, IL-1β, and IL-6—cytokines that reduce insulin signaling and alter steroid hormone receptor function (Cani et al., 2007).
  • Permeability increases immune load and oxidative stress, thereby consuming methyl donors and glutathione needed for safe phase II detox (methylation, glucuronidation, sulfation) of estrogens.

I screen for these drivers whenever patients report PMS, heavy cycles, PCOS features, endometriosis pain, acne or hair loss, mood changes, fatigue, or autoimmune flares. Correcting the gut often increases the safety and efficacy of hormone therapy.

Estrogen Metabolism 101: Enterohepatic Circulation and the Estrobolome

The liver metabolizes estrogens via phase I hydroxylation (CYP1A1, CYP1B1) and phase II conjugation (COMT methylation, glucuronidation, sulfation). Conjugated metabolites pass into bile and should be excreted. In dysbiosis, microbial beta-glucuronidase deconjugates these estrogens, promoting reabsorption and recirculation—the biochemical basis of “estrogen dominance,” even with careful dosing (Plottel & Blaser, 2011).

  • 2-hydroxylation generally produces less proliferative metabolites.
  • 4- and 16α-hydroxylation yield more proliferative or potentially genotoxic metabolites if methylation and conjugation are suboptimal.

In complex cases or when there is a family history of estrogen-dependent cancers, I consider urinary metabolite testing to map pathways and guide targeted support.

PCOS, Endometriosis, and Autoimmunity: What the Microbiome Adds

Recent studies sharpen the microbiome’s role:

  • PCOS: Dysbiosis with fewer SCFA producers and higher LPS correlates with insulin resistance, hyperandrogenism, and impaired GLP-1 signaling (Lindheim et al., 2017; Qi et al., 2019). Restoring butyrate producers improves metabolic tone.
  • Endometriosis: Altered microbiota, increased permeability, and immune activation correlate with symptom severity. Increased beta-glucuronidase raises estrogen recirculation that can exacerbate lesions and pain (Chen et al., 2017; Jiang et al., 2017).
  • Autoimmunity: Barrier dysfunction and loss of tolerogenic species permit pathobiont translocation and molecular mimicry, priming autoimmune activity (Manfredo Vieira et al., 2018).

Clinical translation: Addressing the gut can reduce hormone dosing requirements, expand the therapeutic window, and stabilize mood, sleep, and metabolism.

The Simple Question with Big Impact: Are You Pooping Daily?

I ask every patient: “Do you have a daily bowel movement?”

  • Estrogen metabolites exit via bile and stool. Constipation increases residence time, giving beta-glucuronidase more opportunity to deconjugate and recirculate estrogens.
  • Correcting bowel habits is a core risk-reduction strategy for estrogen-driven conditions.

Practical steps I use:

  • Increase hydration and electrolytes.
  • Ramp fiber to 25–35 g/day; add PHGG (partially hydrolyzed guar gum) 4–6 g/day for low-bloat prebiotic support.
  • Add magnesium glycinate or citrate at night for stool regularity and sleep.
  • Encourage postprandial walks and vagal toning (slow exhale breathing, humming).

A 3-by-3 Framework for Gut Repair: Remove, Replace, Repair

To keep things doable, I use a 3-by-3 approach:

  1. Remove/Reduce Irritants
  • Clean up the diet: favor whole foods; limit alcohol, ultra-processed items, added sugars; consider a gluten-light or gluten-free trial for sensitive individuals.
  • Medication review: minimize NSAIDs and PPI overuse when clinically safe.
  • Stress load: hard-wire breath work, walks, and sleep hygiene.
  1. Replace and Restore
  • Fiber and prebiotics: 25–35 g/day total fiber; add PHGG for gentle SCFA support.
  • Probiotics: multi-strain Lactobacillus and Bifidobacterium blends (e.g., L. rhamnosus GG, B. lactis) for barrier and immune balance.
  • Digestive support: bitters and meal hygiene for hypochlorhydria/slow motility; phosphatidylcholine and balanced fats for bile flow.
  1. Repair and Rebalance
  • Barrier repair: L-glutamine 5 g/day, zinc carnosine, N-acetyl-D-glucosamine, omega-3s as indicated.
  • Inflammation control: Berberine for dysbiosis-associated endotoxemia; curcumin and quercetin for NF-κB calming.
  • Lifestyle anchors: 150 minutes/week activity; 10-minute post-meal walks; consistent 7–9 hours of sleep.

Why this approach works:

  • Prebiotics increase SCFAs, reinforce tight junctions, and support T-regs via HDAC inhibition.
  • Probiotics competitively inhibit pathobionts, reduce beta-glucuronidase activity, and enhance mucosal IgA.
  • L-glutamine fuels enterocytes and accelerates barrier recovery.
  • Berberine improves the microbial balance and activates AMPK to improve insulin sensitivity.

Nutrient Foundations for Receptor-Level Hormone Action: D, K2, A, Magnesium, Iodine, Selenium, and Methylation

I frequently see patients with robust serum hormones but poor tissue effects. The missing link is often receptor signaling, cofactors, and membranes.

  • Vitamin D3 behaves like a secosteroid hormone that modulates transcription through the VDR. Low vitamin D is associated with all-cause and cardiovascular mortality and can blunt androgen signaling even when total testosterone appears normal (Pilz et al., 2011; Holick, 2017).
  • Magnesium is a cofactor for D activation (25- and 1α-hydroxylases); deficiency dampens VDR signaling (Rosanoff et al., 2016).
  • Vitamin K2 directs calcium into bone and away from soft tissues by activating matrix Gla protein and osteocalcin; it complements D to protect vessels and build bone (Schurgers & Vermeer, 2000; Beulens et al., 2013).
  • Vitamin A supports epithelial integrity, immune balance, and nuclear receptor synergy with vitamin D.

I often use an ADK formula (D3 with K2 and A) alongside magnesium to safely improve receptor-mediated effects, while monitoring 25(OH)D, calcium, and PTH (Rosen et al., 2012).

Thyroid resilience: iodine and selenium synergy

  • Iodine is essential for T4/T3 synthesis, but safe utilization depends on selenium-dependent enzymes (glutathione peroxidases, thioredoxin reductases) to quench the H2O2 generated during iodide organification (Ventura et al., 2017).
  • Inadequate selenium increases oxidative stress at the thyroid, raising the risk of autoimmunity when iodine intake rises (Gartner & Gasnier, 2003).
  • I pair iodine (200–400 mcg) with selenium (100–200 mcg selenomethionine) and often zinc (10–30 mg), titrated to labs and symptoms (Zimmermann & Boelaert, 2015).

Methylation for estrogen safety

  • Methylated B vitamins—methylfolate and methylcobalamin—support COMT-mediated methylation of catechol estrogens, reducing genotoxic stress and stabilizing phase II clearance.

These micronutrients are the bedrock that allows hormones to “dock” and trigger healthy cellular responses.

DIM and Estrogen Metabolites: Steering Toward Safer Pathways

Diindolylmethane (DIM) shifts estrogen metabolism toward 2-hydroxylation and away from 16α- and 4-hydroxylation pathways associated with proliferative and genotoxic risk (Zeligs et al., 2006; Reed et al., 2006). Preclinical studies suggest that DIM may also upregulate BRCA1 signaling and promote apoptosis in cancer cell lines (Fan et al., 2009; Li et al., 2010).

How I apply it:

  • Women with estrogen-dominant symptoms or unfavorable metabolite profiles: 150–300 mg/day, adjusted to labs and tolerance.
  • Men with prostate risk or aromatization-driven symptoms: 300–600 mg/day, personalized.
  • I pair DIM with omega-3s, iodine/selenium, and fiber/probiotics to support the entire estrobolome–liver–stool axis.

Rationale: By changing metabolite balance and supporting conjugation, DIM decreases receptor overstimulation and DNA-adduct risk while improving symptom stability.

Shilajit for Free Testosterone and Mitochondrial Support

Some patients—particularly young males—present with high total testosterone but low free testosterone and low vitality. Shilajit, a purified, fulvic-acid–rich resin, has randomized data showing increases in total (~31%), free (~51%), and DHT (~37%) over ~90 days at 250 mg twice daily (Pandit et al., 2016). Mechanisms likely include improved mitochondrial function, nutrient transport, and hypothalamic–pituitary–gonadal signaling.

How I use it:

  • In those seeking endogenous support without exogenous hormones, I combine shilajit with vitamin D, magnesium, zinc, B12, and iodine/selenium when indicated, then track changes in free T, SHBG, energy, and body composition.

Why this works: Enhancing mitochondrial ATP and cofactor availability raises tissue responsiveness; changes in binding dynamics can increase the bioactive fraction without pushing total testosterone to excessive levels.

Vitamin D as a Systemic Modulator: Barrier, Immunity, and Receptors

I routinely optimize vitamin D because it acts at the intersection of immunity, barrier integrity, and endocrine signaling. Observational data tie suboptimal 25(OH)D to higher risks across diseases (Bouillon et al., 2019). Mechanistically, D supports tight junction proteins, cathelicidin, and endocrine receptor sensitivity. Clinically, many patients feel “stuck” until D is restored to an optimal range; I often target 60–80 ng/mL with appropriate monitoring to avoid hypercalcemia (Holick, 2017; Rosen et al., 2012).

Integrative Chiropractic Care: The Neuroimmune–Endocrine Interface

As a chiropractor and nurse practitioner, I see daily how autonomic balance, fascial mobility, and pain modulation determine whether patients can absorb nutrients, move consistently, and sleep well—foundations for endocrine success.

  • Vagal tone and motility: Gentle spinal and cervical adjustments can influence autonomic balance, improving gut motility, secretory IgA, and anti-inflammatory vagal pathways. Patients with low vagal tone present with constipation, bloating, and poor stress resilience.
  • Fascia and diaphragm: Thoracolumbar fascial restrictions and diaphragmatic stiffness impair breathing mechanics and lymphatic flow, promoting sympathetic overdrive. Mobility restores circulation and reduces pain.
  • Pain reduction without NSAIDs: Lowering nociception decreases cortisol and protects the mucosa from NSAID-induced permeability.
  • Behavioral activation: When pain decreases, patients walk, train, and sleep—activities that increase SCFAs, improve insulin sensitivity, and stabilize mood.

These neurophysiologic effects align with published observations on autonomic modulation and musculoskeletal care (Pickar, 2002; Lehman et al., 2012) and help nutrition and endocrine strategies “stick” in daily life.

For examples of how we operationalize this, see my resources at Chiromed and my professional updates on LinkedIn.

A Phased, Clinic-Ready Protocol for Gut and Hormone Optimization

I layer care to build momentum and safety.

Phase 1: Stabilize and Build Trust (Weeks 0–4)

  • Ensure daily bowel movements; add PHGG, hydration, and magnesium as needed.
  • Start a multi-strain probiotic (Lactobacillus + Bifidobacterium).
  • Begin vitamin D3 with K2 and magnesium; consider ADK formulations.
  • Introduce walks after meals and fixed sleep schedules.
  • Provide chiropractic adjustments and diaphragmatic work to normalize autonomics and reduce pain.
  • Baseline labs: CBC, CMP, 25(OH)D, calcium, PTH, thyroid panel (TSH, free T4/T3), thyroid antibodies as needed, ferritin, B12, folate, magnesium, zinc, selenium, CRP, fasting insulin/glucose, lipid profile, estradiol, total and free testosterone, SHBG.

Phase 2: Targeted Gut Repair and Hormone Pathways (Weeks 4–12)

  • Add L-glutamine 5 g/day for barrier support when indicated.
  • Short berberine course for endotoxemia/dysbiosis; replete with probiotics.
  • Add DIM if clinical or metabolite data show proliferative pathways.
  • Start a methylated B complex to support COMT and phase II detox.
  • Maintain chiropractic care cadence for autonomic and biomechanical resilience.

Phase 3: Personalize, Monitor, and Maintain (Months 3+)

  • Reassess symptoms, bowel habits, and targeted labs; titrate to the lowest effective doses.
  • Reinforce lifestyle anchors: fiber intake, movement, sleep, and stress practices.
  • Schedule periodic tune-ups for the spine, fascia, and breath mechanics to sustain vagal tone and support recovery.

This sequencing respects physiology and behavior: patients feel better first, then commit to more significant changes—resulting in better adherence and durable outcomes.

Special Focus: PCOS and Endometriosis

PCOS

  • Emphasize insulin sensitization through fiber, postprandial walks, resistance training, and, where appropriate, berberine.
  • Reduce LPS: probiotics, polyphenols, and barrier repair to lower endotoxemia.
  • Consider inositols for ovulatory support alongside gut therapy.
  • Monitor androgenic symptoms as gut protocols progress; improvements often track with better bile acid and SCFA signaling.

Endometriosis

  • Reduce beta-glucuronidase pressure via probiotics and fiber to limit estrogen recirculation.
  • Calm neuroimmune inflammation with omega-3s, curcumin, and sleep optimization.
  • Use gentle movement and manual therapy to address pelvic floor tension and diaphragm mobility; sympathetic downshift reduces pain tone.
  • Coordinate with gynecology; gut protocols augment, not replace, indicated care.

Case Reflection: High Total Testosterone, Low Vitality

I saw an 18–19-year-old male with low mood, low energy, weight gain, and “low-T” symptoms. His total testosterone was ~900 ng/dL—clearly not low. What we found: very low vitamin D, low B12, and signs of micronutrient insufficiency. I started a robust B-complex, ADK (D3 + K2 + A), iodine paired with selenium, and magnesium. At follow-up, his mother said, “He’s a totally different person.” Energy, mood, and cognition improved, and multiple medications were discontinued. The physiology: hormones were present, but receptor signaling and cellular machinery were underpowered. Restoring micronutrients enabled the hormones to “work.”

In other young men with high total but low free testosterone, I have added shilajit and structured resistance training. Free fractions improved, and vitality followed—without pushing total testosterone into excess.

Safety, Lab Monitoring, and Personalization

  • Monitor: 25(OH)D, calcium, PTH for vitamin D repletion; thyroid panel and antibodies for iodine–selenium strategies; ferritin, B12, folate, magnesium, zinc, selenium, CRP for micronutrient and inflammatory status; sex hormones including free testosterone and SHBG.
  • Adjust doses to labs and symptoms. If vitamin D stays low despite oral dosing, assess bile flow, fat absorption, and adherence; consider supervised loading.
  • Cautions:
    • Vitamin A: avoid hypervitaminosis; use caution in pregnancy.
    • Iodine: go slowly with autonomous nodules or hyperthyroidism; collaborate with endocrinology.
    • Zinc: long-term high dosing can lower copper; keep the balance.
    • DIM and shilajit: use third-party-tested products; personalize the dose.
    • Berberine: short targeted courses; watch for GI sensitivity and drug interactions.

How Integrative Chiropractic Care Complements Endocrine and Gut Strategies

Mechanistically, chiropractic-informed care bridges biochemistry and behavior:

  • Reduces nociception and sympathetic overdrive, lowering cortisol drag on thyroid conversion and gonadal axes (Lehman et al., 2012).
  • Improves respiratory mechanics and fascial glide, supporting lymphatic flow, nutrient delivery, and waste clearance.
  • Enhances vagal tone, supporting motility, secretory IgA, and peristalsis—foundations for microbiome stability.
  • Facilitates movement prescriptions (resistance training, mobility, aerobic intervals) that reduce aromatase activity, improve insulin sensitivity, and raise androgen receptor density.

In my practice, patients combining endocrine protocols with spinal–fascial optimization report better sleep, steadier energy, more predictable lab trajectories, and lower required doses—an elegant synergy of systems biology and hands-on care. Explore our integrative approach at Chiromed and my professional notes on LinkedIn.

Why Each Technique Matters: Systems Biology Rationale

  • Fiber/PHGG: Feeds SCFA producers, tightens junctions, and supports GLP-1 signaling.
  • Probiotics: Reduce beta-glucuronidase, improve barrier integrity, and temper endotoxemia.
  • L-glutamine: Primary fuel for enterocytes; accelerates epithelial repair.
  • Berberine: Reshapes the gut microbiota, lowers LPS levels, and activates AMPK to improve insulin sensitivity.
  • DIM: Steers estrogen toward 2-hydroxylation, lowering proliferative load.
  • Methylated B vitamins: Enable COMT activity and conjugation; reduce genotoxicity of catechol estrogens.
  • Vitamin D + K2 + A + Mg: Align receptor signaling and calcium kinetics; protect vessels and bone.
  • Iodine + selenium: Support thyroid synthesis while detoxifying H2O2 to prevent autoimmune escalation.
  • Shilajit: Enhances endogenous androgens via mitochondrial and HPG-axis support.
  • Chiropractic care: Normalizes autonomic function, reduces pain, and supports movement habits that sustain microbiome and endocrine gains.

Each intervention nudges a different lever; together, they realign the system.

Clinical Observations from Practice

Across patient cohorts at my clinic, we see reproducible patterns:

  • Resolving constipation reduces PMS and “estrogen rollercoaster” symptoms within weeks.
  • Regular adjustments correlate with improved sleep and stress tolerance, enabling consistent training and meal timing that benefit the microbiome.
  • Vitamin D optimization often coincides with improved mood, less joint pain, and better responses to both gut and hormone protocols.

These observations are consistent with the mechanistic and clinical literature, reinforcing the rationale for why foundational steps deliver outsized results. For more, visit Chiromed and my LinkedIn updates.

References

Hormones: A Comprehensive Guide for Thyroid Optimization

Learn about thyroid optimization for hormones and their vital role in your health. Optimize your thyroid for improved vitality and balance.

Abstract

I wrote this educational post to share how I evaluate and treat persistent hypothyroid symptoms when traditional, TSH-centered therapy falls short. Drawing on my personal journey of living without a thyroid and more than a decade in integrated clinical practice, I explain why patients can feel hypothyroid with “normal” lab values, how the deiodinase system and reverse T3 shape symptoms, and where free T3 offers a more reliable clinical compass. I also detail why some people do better on combination T4/T3 therapy or desiccated thyroid, how nutrient cofactors like iron and selenium transform outcomes, and why lab timing and dose splitting matter. I show where integrative chiropractic care fits by improving autonomic balance, pain, sleep, and movement capacity—factors that directly influence hormone conversion and tissue response. Throughout, I integrate modern, evidence-based research and reference leading studies in endocrinology, cardiology, neurology, and rehabilitation. You will find a precise, step-by-step framework to help patients move from biochemical uncertainty to functional recovery.

The Journey Without a Thyroid and How It Shapes My Care

I practice medicine and chiropractic with a unique perspective. Many patients were required to complete thyroid removal. In the era before recombinant TSH, I experienced diagnostic withdrawal phases that pushed my TSH above 150 mIU/L. They felt the hard edge of metabolic shutdown—cold intolerance, constipation, bradypsychia (slowed thinking), and the kind of profound fatigue that flattens life.

Those deeply personal experiences transformed how I listen to and care for patients. Over the last 14 years, I have provided longitudinal care for more than 9,000 patients with thyroid-related conditions. I repeatedly see the gap between “lab-normal” and truly feeling normal in daily life. Many arrive with TSH values in range on levothyroxine yet still grapple with persistent symptoms.

In my chiropractic practice, I integrate precise spinal adjustments to optimize nervous system function and autonomic balance, thereby directly supporting endocrine regulation and helping close that gap. Patients often describe the full spectrum of thyroid imbalance: classic hypothyroid effects such as fatigue, weight gain, hair thinning, low mood or depression, brain fog, slowed cognition, dry skin, muscle weakness, constipation, cold intolerance, and exercise intolerance; as well as disruptive hyperthyroid symptoms including unintended weight loss despite increased appetite, heat intolerance, anxiety or irritability, rapid heartbeat or palpitations, diarrhea, tremors, restlessness, insomnia, and excessive sweating.

Many therapeutic journeys have reached the same conclusion: many patients need a more nuanced approach than T4 replacement alone—sometimes adding T3, correcting nutrient gaps, addressing gut-liver dysfunction, or resolving autonomic imbalance. These lived lessons anchor the whole-person framework I share here.
References for clinical updates and case observations:
ChiroMed: https://chiromed.com/
LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Thyroid Physiology And Why A Normal TSH Can Mask Low Tissue Thyroid Action

To fully explain persistent symptoms, I begin with the hypothalamic-pituitary-thyroid (HPT) axis and tissue-level control:

  • The hypothalamus releases TRH, prompting the pituitary to release TSH, which signals the thyroid to make T4 and T3.
  • T3 is the bioactive hormone that binds to nuclear thyroid receptors (TRα, TRβ), upregulates mitochondrial and metabolic genes, and drives energy production.
  • Most circulating T3 is made in peripheral tissues by deiodinases. D1 and D2 convert T4 to T3, while D3 shunts T4 into reverse T3 (rT3)—an inactive isomer that competes with T3 for receptor access.

When inflammation, stress, or nutrient deficiency suppress D1 and favor D3, the result is a “low T3–high rT3” pattern. The pituitary, cushioned by local D2 activity, may “feel” replete and keep TSH within range, while muscles, brain, liver, and heart remain T3-deficient. This is how people feel hypothyroid despite a “normal” TSH.

  • Deiodinase and tissue signaling overview: (Bianco & Kim, 2018)
  • Non-thyroidal illness and low T3 physiology: (Peeters, 2017)
  • Transporter and receptor influences on intracellular signaling: (Friesema et al., 2010)

Citations:

Why Free T3 Predicts Function Better Than TSH During Treatment

In practice and research, free T3 correlates more tightly with energy, thermoregulation, cognition, and cardiometabolic outcomes than TSH when therapy is underway. While TSH is an excellent screening tool in untreated populations, it does not reliably reflect tissue thyroid status once exogenous hormone is introduced. Peripheral tissues depend on D1, which is easily downregulated by stress and illness. The pituitary’s reliance on D2 allows TSH to normalize even as free T3 remains low or rT3 rises.

  • Cardiovascular findings consistently link low T3 with worse outcomes; TSH often shows weak or no association (Dimitriadis et al., 2014; Iervasi et al., 2010).
  • In critical illness and ARDS, low T3 predicts higher mortality and delayed recovery (Wajner & Maia, 2015).

Citations:

The Reverse T3 Brake And The Conversion Ecology

I teach patients to think of reverse T3 as a physiologic brake. Under stress, inflammation, infection, caloric restriction, or high T4 loads, D3 increases and shunts T4 into rT3. Elevated rT3 effectively blocks T3’s action by competing for receptor and transport access.

  • Symptoms of high rT3/low T3: fatigue, cold intolerance, constipation, dry skin, sluggish thinking, reduced exercise tolerance.
  • Clinical reasoning: Adding more T4 in a high rT3 state often worsens the problem by feeding the brake. We must address stressors, reduce inflammation, optimize cofactors, and, when indicated, add physiologic T3.

Mechanistic reviews:

Levothyroxine Alone: When The Assumptions Fail

The traditional assumption was that T4-only therapy would convert adequately to T3 and fully resolve symptoms. Many patients do improve on levothyroxine. Yet a meaningful proportion remain symptomatic because of impaired conversion or high rT3.

  • Genetic polymorphisms (e.g., DIO2 Thr92Ala) and inflammatory states alter T3 production and action (Panicker et al., 2009).
  • Caloric restriction, illness, and iron deficiency shift deiodinase activity away from T3 (Stott et al., 2019).

A physiologic alternative is to use combination therapy (T4 + T3) or desiccated thyroid (DTE) for select patients with persistent symptoms, carefully titrated and monitored for safety.
Citations:

The Testosterone Connection And Metabolic Synergy

Thyroid hormones and androgens co-regulate metabolic rate, muscle protein synthesis, and mitochondrial efficiency:
Hypothyroidism can downregulate androgen receptors; low testosterone reduces muscle mass and worsens fatigue (Kelly & Jones, 2015).

  • Thyroid hormones increase SHBG, thereby altering the free fractions of testosterone and estradiol (Davis & Wahlin-Jacobsen, 2015).
  • Visceral adiposity increases aromatase activity, further lowering free testosterone. Optimizing thyroid action reduces central fat and indirectly improves androgen balance.

Citations:

An Evidence-Guided Evaluation Framework I Use In Clinic

To identify root causes of persistent symptoms, I apply a structured model:

  • Comprehensive thyroid panel and dynamics
    • TSH, free T4, free T3, and reverse T3 to map supply, conversion, and braking.
    • Thyroid antibodies (TPOAb, TgAb) for autoimmunity surveillance.
    • Consistent lab timing relative to dosing.
  • Nutrient and hematologic status
    • Ferritin, iron indices, selenium, zinc, vitamin D, vitamin A, B12; iodine assessment when indicated and carefully monitored.
    • Rationale: cofactors enable hormone synthesis and conversion (Zimmermann & Köhrle, 2002).
  • Inflammation and metabolic health
    • hsCRP, fasting insulin, HOMA-IR, lipids, liver enzymes; body composition for lean mass and visceral fat.
  • Gut-liver axis
    • Screen dysbiosis/SIBO symptoms, celiac markers, NAFLD risk, bile flow, and constipation patterns (Docimo et al., 2021).
  • Autonomic nervous system and stress load
    • HRV, orthostatic vitals, sleep quality, perceived stress.
  • Sex hormones and adrenal rhythm (as indicated)
    • Total and free testosterone, SHBG, estradiol, LH/FSH; DHEA-S; consider cortisol profiles when warranted.

Citations:

Precision Dosing: Why Lab Timing And Dose Splits Matter

When I incorporate T3 (liothyronine) or use desiccated thyroid, I standardize lab draws at five to six hours after the morning dose and split doses to avoid peaks:

  • Pharmacokinetics: Oral T3 peaks about 1–2 hours after ingestion and declines over the next several hours. Drawing at 5–6 hours captures a mid-curve snapshot that is comparable across visits (Ross, 2022; Jonklaas et al., 2019).
  • Dose splitting: I typically use BID or TID schedules (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.) to maintain steady intracellular T3 for mitochondrial throughput, cognitive function, and thermoregulation. This dramatically reduces palpitations and anxiety tied to early peaks.
  • Wearables: I ask patients to track heart rate and sleep. Post-dose pulse spikes confirm kinetic peaks and guide redistribution.

Citations:

Combination Therapy And Desiccated Thyroid: How I Use Them And Why

I consider combination T4/T3 or desiccated thyroid extract (DTE) for patients with persistent symptoms and a lab pattern of low free T3 and/or elevated rT3:

  • Start low and titrate slowly
    • Introduce small, divided T3 doses to avoid peak-related side effects.
    • Maintain a baseline T4 level for substrate, while ensuring receptor activation by T3.
  • DTE practicals
    • Typical starting range: 1–1.5 grains (60–90 mg) daily, individualized to prior T4 dose and sensitivity.
    • Transition approach: a two-week half-and-half overlap (half prior T4 dose plus half new DTE dose) to avoid T3-naïve jitters.
    • Limit large single doses; distribute across the day if a higher total daily dose is needed.
  • Monitoring
    • Symptoms, free T3, free T4, and safety markers (heart rate, blood pressure).
    • Long-term: bone density surveillance when higher T3 exposures are used in specific populations.

Evidence-based and patient preference data:

Nutrient Therapy That Changes Outcomes: The Thyroid

The thyroid hormone is a signal, but the body needs substrates and cofactors to translate that signal into action. I routinely assess and treat:

  • Iron repletion when ferritin is low (often targeting >50–70 ng/mL for thyroid optimization)
    • Iron supports thyroid peroxidase and deiodinase function; low ferritin levels blunt T4-to-T3 conversion and can mimic hypothyroid symptoms.
  • Selenium (100–200 mcg/day from diet/supplement)
    • Supports deiodinase activity and antioxidant defense; may modestly reduce TPO antibodies (Winther et al., 2020).
  • Zinc, vitamin D, vitamin A, and B12
    • Zinc facilitates receptor function; vitamin D modulates immune tone and muscle; vitamin A supports epithelial and receptor dynamics.
  • Protein sufficiency (often 1.2–1.6 g/kg/day)
    • Supports thyroid transport proteins, hepatic conversion, and muscle mass.

Citations:

Integrative Chiropractic Care: Autonomic Regulation, Pain Reduction, And Metabolic Performance

As a DC and APRN, I see daily how neuromusculoskeletal health and the autonomic nervous system shape endocrine outcomes. Integrative chiropractic care fits into thyroid optimization by:

  • Autonomic regulation
    • Gentle spinal manipulation and soft-tissue techniques reduce nociceptive input and sympathetic overdrive, improving vagal tone and HRV. Lower stress signaling supports D1 activity, reduces rT3, and improves sleep quality.
  • Pain reduction
    • By reducing chronic pain, we lower inflammatory cytokines (e.g., IL-6, TNF-α) that suppress deiodinases and disrupt sleep, thereby enabling better hormone conversion and tissue responses.
  • Movement-based care
    • Structured resistance training and aerobic intervals, guided by movement assessment, improve insulin sensitivity, GLUT-4 translocation, and mitochondrial density, amplifying T3’s metabolic impact.
  • Breath and posture
    • Thoracic mobility and diaphragmatic breathing enhance oxygenation, vagal tone, and sleep—key supports for endocrine stability.


Clinical observations:
In my practice at ChiroMed, patients who pair optimized thyroid therapy with chiropractic autonomic optimization, mobility work, and progressive strength programming recover faster, maintain better energy, and sustain fat loss more reliably. See clinical reflections and case pearls:

Metabolic Rehabilitation: Building A Physiology That Welcomes T3

Thyroid optimization alone rarely solves modern metabolic challenges. I employ a pragmatic blueprint:

  • Build muscle first
    • Two or more weekly full-body resistance training sessions with progressive overload. More muscle equals a higher basal metabolic rate and better glucose disposal.
  • Walk the thermostat
    • 7,000–10,000+ daily steps, with postprandial 10–15-minute brisk walks, to blunt glucose excursions and lower inflammation.
  • Prioritize sleep and rhythm.m
    • Stable sleep-wake times, morning light exposure, and evening light reduction improve HPT-axis signaling and insulin sensitivity.
  • Protein-forward nutrition
    • 25–40 g protein per meal; fiber-rich plants and healthy fats; minimize ultra-processed foods.
  • Micronutrient sufficiency
    • Emphasize seafood (selenium, iodine), lean meats (iron, zinc, B12), eggs (vitamin A), and leafy greens (folate, magnesium).
  • Stress modulation
    • Breathing practices, HRV-guided recovery, and time in nature lower cortisol and rT3.
  • Manual and chiropractic care
    • Identify and correct joint restrictions and postural dysfunctions that limit training and raise sympathetic tone.

Epidemiologic context: U.S. obesity prevalence continues to rise, underscoring the need to embed thyroid care within a broader metabolic strategy (CDC, 2023).
Citation:

Thyroid Dysfunction-Video

Safety And Monitoring: Cardiac And Bone Health With T3

I titrate T3 conservatively and monitor:

  • Cardiac status (resting pulse, symptoms; ECG as indicated in arrhythmia-prone patients).
  • Bone health (ensure adequate calcium and vitamin D, prioritize resistance training, and follow DEXA for at-risk individuals).
  • Symptoms and function (energy, thermoregulation, bowel rhythm, cognition, sleep).
  • Free T3/Free T4, with TSH interpreted cautiously under T3-containing regimens.

A key clinical distinction: TSH suppression on therapy is not the same as endogenous hyperthyroidism. In thyroid cancer cohorts, carefully managed TSH suppression does not universally increase atrial fibrillation or osteoporosis risk when free hormones and clinical markers are appropriately monitored. We individualize targets rather than relying on a single lab threshold.
Reviews:

Standardizing Testing: Reducing Noise And Improving Decisions

The most powerful lever in precision thyroid care is standardization:

  • Fix dosing times (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.).
  • Lock blood draws at five to six hours after the morning dose.
  • If patients arrive outside the window, reschedule to keep results comparable.
  • Use simple EMR notes to track outcomes: “Free T3 improved; patient reports better focus and energy; no adverse effects at standard draw; pulse stable.”

This rigor transforms guesswork into reliable, reproducible decisions.
Citations:

Case Patterns From Practice: How The Physiology Plays Out

The “stuck but strict” patient

  • A woman on levothyroxine with normal TSH but persistent fatigue and weight gain. Ferritin was 18 ng/mL; vitamin D was 22 ng/mL; rT3 was elevated. After iron and vitamin D repletion, post-meal walking, and low-dose T3 add-on, energy rose within weeks. Resistance training resulted in a 6% relative reduction in body fat over four months; we later tapered levothyroxine as conversion normalized.

The “pain-metabolism loop.”

  • A man with low back pain avoided exercise and gained weight while on stable thyroid replacement therapy. Integrative chiropractic care reduced pain and improved mobility. We added a graded strength plan and sleep coaching; HRV improved. With modest T3 addition, he reported clearer thinking and greater stamina.

The”testosterone trap.”

  • A man sought testosterone for fatigue and low libido. Evaluation revealed low-normal free T3, elevated rT3, high stress, and poor sleep. We prioritized thyroid optimization, sleep, and resistance training. Free testosterone improved without exogenous testosterone; symptoms resolved.

Clinical notes and similar cases:

Practical Steps For Patients And Clinicians

Patients

  • Ask for a comprehensive thyroid panel: TSH, free T4, free T3; consider reverse T3 if symptoms persist.
  • Check ferritin, selenium, zinc, vitamin D, and B12; discuss iodine only with clinical guidance.
  • Standardize dosing times and lab draw timing; split doses if needed to reduce peaks.
  • Build muscle, walk after meals, and protect sleep; track pulse and sleep with wearables if possible.
  • Consider integrative chiropractic care to improve pain, autonomic balance, and movement capacity.

Clinicians

  • Treat the person, not just the lab. If symptoms persist with “normal” TSH, investigate conversion ecology, cofactors, and comorbidities.
  • Consider cautious T4/T3 combination or DTE trials with standardized monitoring and safety tracking.
  • Pair endocrine therapy with nutrition, sleep, stress care, and chiropractic/rehab partners.
  • Reassess as inflammation, body composition, and fitness improve; the right dose today may be excessive in six months.

Closing Perspective: Aligning Therapy With Physiology

Living without a thyroid taught me respect for the complexity of endocrine physiology and the limits of single-number thinking. Care improves when we align therapy with how the body actually works: ensure adequate hormone supply; correct cofactor deficiencies; calm the autonomic nervous system; build muscle; and remove friction points such as pain, inflammation, and poor sleep. When we combine personalized thyroid replacement, targeted nutrient therapy, and integrative chiropractic care within a metabolic rehabilitation framework, patients stop treading water and begin moving forward.

References

SEO tags: thyroid optimization, free T3, reverse T3, deiodinase enzymes, levothyroxine, liothyronine, T4 T3 combination therapy, desiccated thyroid, ferritin and thyroid, selenium thyroid, autonomic balance, integrative chiropractic care, HRV thyroid, lab timing thyroid, split dosing T3, Hashimoto’s treatment, metabolic rehabilitation, resistance training hypothyroidism, gut liver thyroid axis, suppressed TSH safety, Dr. Alexander Jimenez,

Hormone Balance, Iron Health, and Contraceptive Care

Hormone Balance, Iron Health, and Contraceptive Care

Hormone Balance, Iron Health, and Contraceptive Care

Abstract

As a clinician blending chiropractic, functional medicine, and advanced nursing practice, I see how hormone physiology, micronutrients, and systems biology converge to shape health, recovery, and resilience. In this educational post, I walk you through practical, evidence-informed strategies for evaluating iron deficiency and ferritin; interpreting cortisol and thyroid dynamics; selecting and titrating progesterone, estrogen, and testosterone in complex scenarios (PCOS, IUD selection, male fertility and TRT rebound, TIA and stroke risk considerations, endometriosis, and menopause); and understanding the nuanced oncology context around DCIS and hormone receptors. I also explain how integrative chiropractic care fits into these plans by balancing the nervous and hormone systems, improving body functions, and supporting health through hands-on therapy, exercise, sleep, and diet. Throughout, I present current literature from leading researchers and add real-world observations from my practice (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST) to help you translate physiology into precise, patient-centered care.

Foundations Of Identity In Care Planning And Clinical Context

  • Why this matters: Many patients navigate multiple identities—athlete and parent, caregiver and executive, patient and advocate. Clinically, multiple identities often map onto competing physiological stresses: sleep compression, high allostatic load, and variable patterns of nutrition and movement. Recognizing these factors is the first step in aligning care with lived realities.
  • Integrative chiropractic fit: In my clinic, identity-informed care plans build adherence. When I address spine and fascial mechanics and autonomic balance with targeted manual therapy, patients experience immediate relief that reinforces engagement with longer-term hormonal and nutritional strategies. Clinically, I see better follow-through on lab timing, supplement dosing, and structured movement when the body feels aligned and capable.

Iron Physiology, Ferritin, And Root-Cause Mapping

Understanding iron requires separating storage, transport, and utilization:

  • Key biomarkers:
    • Serum ferritin: a proxy for iron stores but an acute-phase reactant—elevates with inflammation (hepcidin-mediated sequestration).
    • Serum iron and transferrin/TIBC: reflect circulating iron and binding capacity.
    • Transferrin saturation (%): often the most useful single index with ferritin.
    • Reticulocyte hemoglobin (CHr) and soluble transferrin receptor (sTfR): help distinguish true deficiency from anemia of inflammation.

Physiology in brief:

  • The liver peptide hepcidin governs iron absorption and release from macrophages. Inflammation increases hepcidin, lowering absorption and locking iron in stores—low iron availability with normal/high ferritin.
  • True iron deficiency presents with low ferritin, low iron, high TIBC, and low transferrin saturation. Anemia of chronic inflammation shows low iron, low/normal TIBC, and normal/high ferritin.

Why patients stay iron-deficient:

  • Decreased intake or high phytate/polyphenol diets limit absorption.
  • Malabsorption: hypochlorhydria, celiac spectrum, SIBO, gastric bypass.
  • Losses: heavy menses, GI blood loss, frequent phlebotomy, and endurance training.
  • Special populations: neonates can experience early postnatal physiologic shifts; in adults, postpartum, post-surgery, and endurance athletes require tailored screening.

Clinical approach I use:

  • Map the cause: hydration status, GI absorption, occult bleeding (including fecal immunochemical testing), menstrual history, PPI use, celiac panel if indicated, and inflammatory markers (CRP, ESR).
  • Replace iron physiologically: I favor alternate-day oral iron to align with hepcidin’s diurnal rhythm and reduce GI side effects, supported by recent randomized trials showing improved absorption with every-other-day dosing (Stoffel et al., 2017). Using ferrous bisglycinate or heme iron polypeptide can enhance tolerance.
  • Repletion targets: Bring ferritin to symptom-relief thresholds (often 50–100 ng/mL for fatigue and hair loss), then sustain. Monitor hemoglobin, ferritin, and transferrin saturation every 8–12 weeks during repletion.

Integrative chiropractic fit:

  • Manual therapies that improve thoracic mobility and diaphragmatic excursion enhance vagal tone and GI perfusion, supporting absorption. Coaching on timing iron away from calcium and with vitamin C-rich foods further increases uptake. I often see faster symptom improvement when we combine postural breathing retraining and gentle aerobic conditioning with iron repletion.

Hormonal IUDs, Progestin Families, And Thrombotic Risk

Not all progestins are the same. Families differ in androgenicity and thrombotic risk:

  • Levonorgestrel (Mirena and similar): primarily a local uterine effect with low systemic levels; robust evidence supports low VTE risk compared with systemic progestins (ACOG, 2022).
  • Norethindrone: different side-effect profile and hepatic metabolism from progesterone; systemic exposure carries VTE risk similar to combined oral contraceptives when used in combination with estrogen.
  • Biologic progesterone (micronized) differs from synthetic progestins in receptor activity and in metabolites (e.g., allopregnanolone), which influence mood and sedation.

Why are Levonorgestrel IUDs often well tolerated?

  • The local endometrial action results in reduced systemic exposure, decreased bleeding, and endometrial protection, with a favorable safety profile. This is one reason neurosurgical and periprocedural contexts prefer local or targeted effects when feasible—namely, to reduce systemic adverse events.

Integrative chiropractic fit:

  • Pelvic floor integration matters. I routinely coordinate pelvic floor assessment and diaphragmatic mechanics with IUD choice. Improved lumbopelvic control and reduced sympathetic arousal can decrease cramping and improve IUD tolerance.

Progesterone Strategy In Sensitive Patients And PCOS Contexts

Clinical problem: Some patients with PCOS or HPA dysregulation report mood lability with oral progesterone.

Physiology:

  • Oral micronized progesterone converts to allopregnanolone, a positive allosteric modulator of GABA-A receptors. In most, this is anxiolytic; in a sensitive minority, neurosteroid fluctuations can provoke dysphoria.
  • Sublingual and transdermal routes bypass some first-pass metabolism, altering metabolite profiles and CNS effects.

My approach:

  • Start with a low-dose oral micronized progesterone (e.g., 100 mg qHS) to promote sleep and provide endometrial protection. If not tolerated:
    • Switch to a sublingual troche at half the equivalent oral dose (sublingual tends to achieve higher bioavailability; clinically, 100 mg sublingual can approximate 200 mg oral).
    • Quartering a 200 mg troche yields ~50 mg sublingual aliquots for fine titration.
  • Why this works: By modulating route and dose, we can smooth neurosteroid peaks, reduce daytime sedation, and maintain endometrial safety when used with estrogen.
  • For PCOS on androgen therapy: Balance is critical. A small androgen signal can be synergistic for mood, energy, and libido, but carefully calibrate it with estrogen and progesterone to avoid endometrial hyperplasia, acne, or dyslipidemia. Track SHBG, lipids, and insulin resistance.

Integrative chiropractic fit:

  • Autonomic stabilization through cervical-thoracic manipulation and breathing retraining reduces adrenergic drive that often amplifies progesterone sensitivity. When we address sleep quality and nocturnal bruxism with TMJ and cervical work, I see smoother adaptation to progesterone in practice.

Cortisol Testing: Salivary Profiles Versus Serum

Why measure multiple points:

  • Cortisol follows a diurnal curve: a peak within 30–45 minutes after waking (CAR) and a gradual decline throughout the day. A single AM serum cortisol measurement may miss dysregulated patterns.
  • A 4–5-point salivary cortisol series captures CAR, midday, afternoon, and evening levels—useful for sleep disturbances, burnout, and suspected HPA axis alterations (O’Connor et al., 2021).

When I choose each:

  • For pattern analysis and sleep complaints: multi-point salivary cortisol.
  • For adrenal insufficiency screening or acute illness: AM serum cortisol ± ACTH stimulation.

Integrative chiropractic fit:

  • Chiropractic care and breath-led movement can normalize autonomic balance, often flattening hyper-adrenergic spikes that correlate with evening cortisol elevations. I pair care with light-in-the-morning, dim-in-the-evening routines to reinforce circadian rhythms.

Male Fertility, Clomiphene, And TRT Rebound

In men in their 20s–30s with low testosterone who want fertility:

  • I avoid long-term estrogen receptor blockade. Short courses of clomiphene citrate (3–6 months) can increase LH/FSH levels, thereby increasing endogenous testosterone and sperm counts (Helo et al., 2017). It is not for indefinite use due to visual and mood risks and potential lipid changes.
  • Off peptides/TRT: I use timed clomiphene or enclomiphene to accelerate spermatogenesis while lifestyle and nutrition restore HPG axis tone.
  • Foundational first: For younger men, I prioritize diet quality, sleep, resistance training, weight normalization, and correcting micronutrient levels (vitamin D, B-complex, zinc, magnesium). I frequently see total testosterone rise from low 300s into 700–800 ng/dL over 6–9 months with lifestyle adherence.

Integrative chiropractic fit:

  • Restoring thoracic mobility and rib mechanics improves breathing efficiency and training capacity; correcting lumbopelvic mechanics reduces systemic inflammation from overuse. The autonomic shift toward parasympathetic tone deepens sleep, which is crucial for nocturnal gonadal hormone secretion.

DCIS, Hormone Receptors, And Personalized Risk-Benefit

Terminology and nuance:

  • Ductal carcinoma in situ (DCIS) is a noninvasive neoplastic process confined to the ducts. While often called “stage 0 breast cancer,” it lacks stromal invasion; management varies widely.
  • Receptor positivity (ER, PR, AR) indicates ligand-responsive pathways. Receptors are normal cellular features; their presence does not inherently mandate systemic suppression in all contexts.

Standard-of-care realities:

  • Many oncology pathways default to anti-estrogen strategies (e.g., tamoxifen) in receptor-positive lesions. My stance: align with oncology for invasive disease or recent treatment, but individualize for remote history or post-mastectomy scenarios, considering symptom burden and quality-of-life outcomes (Early Breast Cancer Trialists’ Collaborative Group, 2011; Cuzick et al., 2011).

Clinical reasoning:

  • In a patient decades post-bilateral mastectomy with no residual breast tissue, the theoretical tissue-specific risk is different from that of a patient 6 months post-lumpectomy still on adjuvant therapy. I weigh the systemic benefits of estrogen (bone, vasomotor stability, cognition, urogenital health) against realistic tissue risks, use shared decision-making, and document this via informed consent.

Integrative chiropractic fit:

  • Many of these patients struggle with pain, sleep disruption, and deconditioning. Postural restoration, scar mobility work, and gentle strengthening reduce sympathetic load, allowing lower-dose hormone regimens to achieve symptom control.

TIA, Stroke Risk, And Sex Hormones

Historical concern has linked estrogen to stroke risk, particularly in oral forms and in older trials with higher doses started late after menopause. The modern view:

  • Route matters: Transdermal estradiol has a more favorable thrombotic profile than oral estradiol because it bypasses first-pass hepatic effects on clotting factors (Canonico et al., 2016).
  • Testosterone does not require routine discontinuation after TIA in carefully selected women and men; the focus is on global vascular risk management (blood pressure, glycemic load, sleep apnea, hematocrit monitoring in men on TRT).
  • In patients who received pellet therapy near a TIA event, I evaluate vascular risks comprehensively. Anecdotally and mechanistically, sustained androgen levels do not necessarily precipitate cerebrovascular events; confounding factors (dehydration, arrhythmia, migraine with aura, hypercoagulable states) must be assessed.

Why integrative care helps:

  • Cervical and upper thoracic biomechanical dysfunction can aggravate headaches and sympathetic tone. By improving cervical proprioception, rib mechanics, and breathing patterns, I observe reduced migraine frequency and better control of blood pressure variability, which complements hormone prudence.

Immediate-Release Versus Extended-Release In Symptom Relief

In my practice, I often choose immediate-release formulations when seeking neurosensory benefits (e.g., anxiolysis, sleep initiation) from agents with CNS effects because:

  • Faster onset can more directly target symptom windows (e.g., bedtime).
  • It allows finer titration and identification of dose-response relationships.

When I choose extended-release:

  • For hormones or agents where steady state is crucial to avoid peaks/valleys, or when side effects are dose-peak-related. Personalization is key.

Endometriosis And Menopause: Progesterone Essentials

Key principles:

  • In menopausal women with a history of endometriosis on estrogen therapy, I favor co-prescribing progesterone even without a uterus. Rationale: ectopic endometrial implants may persist extrauterine and remain hormonally responsive. Progesterone has anti-proliferative effects on endometrial tissue and may reduce the risk of malignant transformation (Vercellini et al., 2014).

Testosterone and endometriosis:

  • Testosterone generally has neutral direct effects on endometriotic lesions; symptom modulation is more indirect (energy, libido, mood). I monitor acne, hair growth, and lipids.

Integrative chiropractic fit:

  • Pelvic and lumbosacral mechanics impact pelvic congestion and pain. Coordinated pelvic floor therapy, sacroiliac mobilization, and graded movement often reduce pain and allow lower estrogen doses with better function.

Thyroid Physiology: T4, Reverse T3, And Desiccated Thyroid

Why do some patients struggle with isolated levothyroxine?

  • T4 to T3 conversion is context-dependent: inflammation (IL-6), chronic stress (cortisol), and caloric restriction increase deiodinase 3, generating reverse T3 as a protective brake.
  • Bolus T4 dosing can, in sensitive patients, drive higher reverse T3 and leave tissues relatively hypothyroid despite normal TSH and free T4.

When I consider combination therapy:

  • If free T3 is low-normal with symptoms and reverse T3 is elevated, a trial of T3 addition or desiccated thyroid can be considered, monitoring HR, BP, and symptoms.
  • Desiccated thyroid includes T1/T2 in addition to T4/T3; while evidence is mixed, some patients report improved well-being (Hoang et al., 2013). The physiologic appeal is a more native ratio of iodothyronines.

Dosing logic:

  • Keep total T3 exposure rational (avoid overtreatment). Many patients do well at conservative desiccated doses (e.g., 60–120 mg with split dosing) or modest liothyronine add-on.
  • If reverse T3 is persistently high, look upstream: inflammation, gut dysbiosis, iron deficiency, sleep apnea, and medications. Raising the dose alone rarely fixes a conversion problem.

Integrative chiropractic fit:

  • By improving sleep quality and decreasing pain, we reduce cortisol and catecholamine tone that can impair peripheral conversion. I frequently pair thyroid adjustments with gut-directed nutrition, iron repletion, and aerobic conditioning to normalize deiodinase activity.

Estriol, Estradiol, And Skin Or Urogenital Targets

  • Estriol (E3) is a weaker estrogen with higher affinity for ER-beta, associated with urothelial and skin benefits and a theoretical reduced proliferative risk profile (Labrie et al., 2017).
  • On its own, estriol is often too weak for vasomotor symptoms; patients may continue to have hot flashes with estriol pellets or low-dose creams.
  • Bi-est combinations (estriol + estradiol) can increase serum estradiol; monitor for bleeding. For vulvovaginal atrophy, low-dose local estradiol or estriol is typically effective with minimal systemic absorption.

Integrative chiropractic fit:

  • Postural improvement, hip mobility, and pelvic floor coordination augment local tissue perfusion and sexual function. Patients often need lower topical doses when musculoskeletal contributors are addressed.

TRT In Men: Hematocrit, Estradiol, And Practical Monitoring

For men on testosterone injections who feel great but develop high hematocrit:

  • Tactics include dose and interval adjustments, switching to transdermal forms, therapeutic phlebotomy if indicated, and addressing sleep apnea, hydration, and iron stores.
  • I monitor hematocrit, estradiol, SHBG, PSA, lipids, and blood pressure. Aromatization to estradiol can be beneficial for bone and mood; I avoid reflexive overuse of aromatase inhibitors and instead optimize dose and lifestyle.

Integrative chiropractic fit:

  • Correcting thoracic outlet and rib mechanics can support breathing and reduce sleep apnea severity alongside weight loss—a key driver of safer TRT hematology.

Gut-First When Thyroid Therapy “Should Work” But Doesn’t

When free T3 is approaching the target (e.g., 4.0+ pg/mL), yet patients still feel unwell:

  • I reassess gut health: dysbiosis, SIBO, post-viral inflammation, food sensitivities. The gut-liver axis modulates thyroid hormone metabolism and immune cross-talk, particularly in Hashimoto’s.
  • I commonly see symptom breakthroughs after:
    • Eliminating trigger foods (gluten in celiac spectrum; individualized otherwise),
    • Repleting selenium, zinc, iron, vitamin D, B12, and magnesium, and
    • Restoring sleep and movement rhythm.

Integrative chiropractic fit:

  • Vagal stimulation through breathing and thoracic mobilization, coupled with graded walking and core stability, improves motility and lowers systemic inflammatory tone.

Clinical Vignettes And Observations From Practice

  • Ferritin plateaus despite oral iron: With alternating-day dosing with vitamin C, stopping concurrent calcium, checking for H. pylori and celiac markers, and adding diaphragmatic breathing drills for reflux, patients often see ferritin rise to 60–100 ng/mL within 12–16 weeks. Combining manual therapy to reduce costal margin restriction improved tolerance of iron and reduced GERD complaints in my clinic.
  • Progesterone intolerance in perimenopause: Switching from 200 mg oral nightly to 50–100 mg sublingual in divided evening doses, plus cervical release and sleep hygiene, stabilized mood and sleep within two cycles for most sensitive patients.
  • Young male with low T and fatigue: A 9-month plan emphasizing whole-food nutrition, vitamin D repletion to 40–60 ng/mL, magnesium glycinate at night, and progressive resistance training raised total testosterone from 320 ng/dL to 760 ng/dL without medications. Thoracic mobility and hip hinge training improved recovery and adherence.
  • Post-DCIS symptom burden: In a patient more than a decade post-bilateral mastectomy with severe vasomotor symptoms, a carefully titrated transdermal estradiol patch with nightly progesterone, plus scapular mobility and postural rehabilitation, improved sleep and cognition. Shared decision-making and documented informed consent were essential.

Why Integrative Chiropractic Care Amplifies Endocrine Therapies

  • Autonomic regulation: Pain and joint dysfunction heighten sympathetic tone, disrupting sleep, glucose metabolism, and thyroid hormone conversion. Manual therapy, spinal mobilization, and breathing retraining shift HRV toward parasympathetic balance, creating a biological environment in which hormones function as intended.
  • Movement economy: Efficient biomechanics reduce inflammatory signaling from microtrauma and improve insulin sensitivity, crucial for PCOS, TRT safety, and thyroid action.
  • Adherence and feedback loops: Rapid musculoskeletal relief builds trust and momentum, making it easier to sustain nutrition, sleep, and medication regimens. Clinically, I consistently see greater lab improvements when patients are engaged in both structured movement and manual care.

Practical Protocol Checklists

Iron and ferritin

  • Assess ferritin, iron, TIBC, transferrin saturation, CRP, ESR, CBC, retic Hb.
  • Identify cause: menses, GI loss, malabsorption, diet, PPI use.
  • Replace with alternate-day dosing; recheck at 8–12 weeks.
  • Add diaphragmatic breathing and gentle conditioning.

Progesterone strategies

  • Start 100–200 mg oral micronized qHS; if intolerant, consider 50–100 mg sublingual divided.
  • For estrogen users, ensure endometrial protection.
  • In the history of endometriosis, there is a continued use of estrogen and progesterone even post-hysterectomy.

Cortisol evaluation

  • Use 4–5-point salivary cortisol to assess diurnal rhythm; AM serum for insufficiency screening.
  • Implement light therapy, sleep hygiene, and autonomic-balancing manual care.

Male fertility/TRT

  • For fertility: short-course clomiphene 3–6 months with lifestyle-based.
  • On TRT: monitor hematocrit, estradiol, SHBG, PSA, BP; address sleep apnea.
  • Optimize resistance training and recovery.

Thyroid optimization

  • If reverse T3 is high and symptoms persist, investigate inflammation and gut.
  • Consider T3 add-on or desiccated thyroid with careful monitoring.
  • Support with selenium, zinc, iron, and vitamin D; improve sleep and stress load.

Estriol/estradiol

  • Use local estradiol or estriol for urogenital symptoms; monitor if combining with estradiol systemically.
  • Expect estriol alone to be too weak for hot flashes.

Closing Perspective

Modern endocrine care thrives at the intersection of precise physiology and whole-person mechanics. When we calibrate hormones thoughtfully, correct nutrient deficits, and restore movement and autonomic balance, patients experience durable improvements in energy, cognition, metabolism, and quality of life. Integrative chiropractic care is not an add-on; it is a force multiplier—aligning the nervous system and musculoskeletal frame to receive and respond to biochemical therapies. My day-to-day observations mirror the literature: when we treat the individual and the system, outcomes follow.

References

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

Abstract

For decades, the standard approach to treating hypothyroidism has centered on a single lab value—Thyroid-Stimulating Hormone (TSH)—and a single medication, synthetic T4 (levothyroxine). However, an increasing body of evidence and extensive clinical observations indicate that this approach is fundamentally flawed for a significant proportion of patients. Many individuals on T4-only therapy continue to suffer from debilitating hypothyroid symptoms like fatigue, weight gain, hair loss, and depression, despite their TSH levels appearing “normal.” This educational post will explore the intricate physiology of thyroid hormone, explaining why T4 is a prohormone and why active T3 is the key to metabolic health. We will deconstruct the limitations of TSH testing, explore the critical process of T4-to-T3 conversion, and introduce the problematic role of Reverse T3. Drawing from the latest evidence-based research and my own clinical experience, I will outline a more comprehensive, patient-centered approach to diagnosing and managing thyroid dysfunction. We will discuss the vital importance of Free T3 (FT3), the shortcomings of standard lab ranges, and the clinical benefits of combination therapy, including Natural Desiccated Thyroid (NDT). Furthermore, I will explain the critical, yet often overlooked, role of iodine and how integrative chiropractic care forms a foundational part of treatment by optimizing nervous system function and supporting the body’s innate ability to heal.

Rethinking Thyroid Care: Moving Beyond Outdated Protocols

As a practitioner with credentials spanning chiropractic, advanced practice nursing, and functional medicine (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), I have dedicated my career to challenging long-held conventions in healthcare to identify what truly works for patients. Today, I want to guide you on a journey into the world of the thyroid, and in doing so, I may need to unravel some of what you’ve come to understand from conventional medical training. My goal is not to create a new, complicated system but to return to a more fundamental, physiological truth. My goal is to assist individuals in returning to a lifestyle that aligns with the natural and optimal design of our bodies.

For over a decade, I’ve focused on this physiological approach, and the feedback from patients at my clinic has been overwhelmingly positive. They feel better, their symptoms resolve, and their lives are transformed. This isn’t based on a fad; it’s grounded in pure physiology. When we appreciate and work with the body’s intricate systems instead of against them, we see profound clinical success. This is particularly true when it comes to the thyroid.

Thyroid Hormone: Your Body’s Metabolic Engine

The thyroid hormone is the master regulator of your metabolism. It dictates the speed of nearly every cellular process in your body. Think of it as the engine’s pace car. It controls:

  • Energy Production: Your overall rate of energy expenditure.
  • Temperature Regulation: Why you might feel cold when others are comfortable.
  • Growth Rates: How fast your hair and nails grow.
  • Gastrointestinal Motility: The speed of your digestive system influences constipation or diarrhea.
  • Cellular Health: Research has even linked low levels of the active thyroid hormone T3 to an increased risk of certain cancers.

The Synthroid Paradox: Normal Labs, Persistent Symptoms

The most widely prescribed thyroid medication in history is levothyroxine, with Synthroid being the most recognizable brand name. Yet, in my clinical practice, I see a daily parade of patients who are taking it and are still miserable. I recently saw a patient who had been on a stable dose of Synthroid for years. Her endocrinologist told her that her labs were perfect, with a TSH of 1.5. Yet, her chart told a different story.

  • Chief Complaint: Fatigue. She was exhausted.
  • Clinical Signs: She was wearing a thick jacket in my office… in the middle of a Texas July.
  • Other Symptoms: She was constipated, and her hair was falling out in clumps.

Her labs may have looked “normal,” but she was a walking textbook of hypothyroid symptoms. If her thyroid replacement were truly working, she would not have these symptoms. Clearly, something was not right.

This scenario is the direct result of a historical confluence of events. Synthroid was approved around 1960 based on two simple criteria: it normalized the TSH, and it didn’t cause immediate harm. It was never studied for its ability to resolve the clinical symptoms of hypothyroidism. Around the same time, the ultra-sensitive TSH assay was developed and quickly became the “gold standard” lab test.

Medical schools and residency programs immediately adopted this new paradigm: Diagnose with TSH, treat with Synthroid, and monitor with TSH. This simplistic loop became dogma. The patient’s well-being became secondary to achieving a “normal” lab number. This is a fundamental flaw in modern endocrinology, and it’s leaving millions of patients to suffer unnecessarily.

Redefining Hypothyroidism: A Deeper Look at T3 and T4

To fix this problem, we must first redefine it. The conventional definition of hypothyroidism is based on a lab test. A functional and more accurate definition focuses on the body’s physiological state.

  • Type 1 Hypothyroidism: This is a production problem. The thyroid gland itself is not producing enough hormone. This can be due to surgical removal, radioactive iodine ablation, autoimmune destruction (Hashimoto’s disease), or glandular burnout from chronic stress.
  • Type 2 Hypothyroidism: This is a conversion problem. The body is unable to effectively convert the inactive storage hormone (T4) into the active, usable hormone (T3). This is where the standard T4-only treatment model fails.
  • Type 3 Hypothyroidism: This is a receptor issue in which cellular receptors become resistant to thyroid hormone, often due to inflammation or illness.

The thyroid gland produces a hormone called thyroxine (T4), which contains four iodine atoms. To become metabolically active, it must lose one iodine atom to become triiodothyronine (T3). T3 has five times the affinity for the thyroid receptor as T4. This means T3 is the hormone that does the heavy lifting. T4 is simply the raw material we store to make T3 whenever we need it. You live off your T3.

The Critical Flaw of TSH Testing and Deiodinase Dysfunction

The TSH test was designed as a screening test for an asymptomatic population to see if they are at risk for a thyroid condition. The inventor of the assay himself stated it was never intended to be used to monitor or guide therapy for a treated patient. So why is it the cornerstone of modern treatment? Because it makes the lab reports look good, providing a false sense of security for practitioners while patients remain unwell.

A pivotal study published by Escobar-Morreale et al. (1997) shed light on this discrepancy. Researchers discovered that the concentration of T3 varied significantly in different tissues throughout the body—the liver, kidneys, and muscles. But there was one place where T3 levels remained stable, even when they were low everywhere else: the brain.

This is because the brain and pituitary gland exhibit a unique, highly concentrated expression of the enzyme deiodinase type 2 (D2). This enzyme is responsible for converting T4 into the active T3. The rest of your body—the periphery—also uses D2, but a host of common stressors can downregulate its activity there while leaving it untouched in the pituitary.

What does this mean? It means your pituitary gland—the very organ that produces TSH—lives in a “T3 bubble,” isolated from the reality of what’s happening in the rest of your body. Your muscles, liver, and fat cells can be starving for T3, but your brain’s T3 level can remain perfectly normal. Consequently, your pituitary sees no problem and keeps the TSH level low and “normal.” Your pituitary gland has no idea what the T3 level is in your big toe, and TSH cannot tell us. This is why a patient can have a “perfect” TSH and still feel terrible.

The Roadblock: Reverse T3 and Poor Conversion

The body has a protective buffer system. Under conditions of stress, inflammation, illness, or nutrient deficiency, the body can divert T4 down a different path. Instead of converting to active T3, it uses a different enzyme, deiodinase type 3 (D3), to convert T4 into an inactive form called Reverse T3 (rT3).

Reverse T3 has the same shape as active T3, allowing it to fit into the thyroid receptor. However, it is a dud. It doesn’t turn the engine on. Instead, it sits there, blocking active T3 from getting to the receptor.

When you give a patient a large dose of T4, especially if they have underlying inflammation or stress, their body often perceives it as a threat. To protect itself from becoming overstimulated, it down-regulates D2 (making less active T3) and up-regulates D3 (making more inactive Reverse T3). The result? The patient’s TSH goes down, their labs look “good,” but their symptoms get worse because their cells are being flooded with an inactive blocker hormone.

A landmark study from Israel beautifully outlines the myriad factors that impair the conversion of T4 to T3:

  • Psychological and Physical Stress: High cortisol is a potent inhibitor.
  • Insulin Resistance and Diabetes: Poor blood sugar control disrupts thyroid function.
  • Inflammation: Cytokines from injury, infection, or chronic disease impair deiodinase enzymes.
  • Autoimmune Disease: Conditions such as Hashimoto’s cause chronic inflammation.
  • Nutrient Deficiencies: Deficiencies in key minerals like iron (ferritin) and selenium are critical cofactors for deiodinase enzymes.
  • Aging: The natural process of aging reduces conversion efficiency, as noted by Duntas & Biondi (2011).

Considering this list, it’s clear that the vast majority of people are not converting T4 to T3 optimally, creating an epidemic of subclinical, functional hypothyroidism.

The Heart of the Matter: Low T3 Syndrome and Cardiovascular Risk

The medical field that has most urgently recognized the danger of this condition is cardiology. An overwhelming body of research now links Low T3 Syndrome directly to poor outcomes in cardiovascular disease. A landmark study by Iervasi et al. (2003) found that in patients with heart disease, a low T3 level was a strong prognostic predictor of death, whereas TSH had no predictive value.

Why is this the case? The myocardium, or heart muscle, is exquisitely sensitive to T3. It relies on adequate T3 for proper contractility, rhythm, and overall function. When serum T3 is low, the heart is essentially starved of its primary metabolic fuel. Historically, how did patients with profound, untreated hypothyroidism die? Almost universally from cardiovascular events. A healthy Free T3 level is a critical component of cardiovascular protection. Patients in the lower part of the lab reference range can have a 33% to 66% higher risk of all-cause and cardiovascular mortality compared to those in the upper range (Pingitore, Iervasi, & Chopra, 2008).

The Problem with “Normal”: Redefining Lab Reference Ranges

This brings me to a fundamental problem in conventional medicine: our reliance on statistically “normal” reference ranges. Let’s say the lab reference range for Free T3 is 2.2 to 4.2 pg/mL. A patient comes to me with a level of 2.3 pg/mL. They have been told their thyroid is “normal.” Yet, they are exhausted, their hair is falling out, and they can’t lose weight.

What does being in the 10th percentile of the reference range truly mean? It means 90% of the population has more of this vital, energy-giving hormone than you do. Does that sound optimal? Of course not. My approach is to move patients from the bottom of the range to a more optimal position, typically aiming for the top quartile (75th percentile and above). I am not treating a lab number; I am treating a patient.

A Modern, Evidence-Based Treatment Protocol

So, how do we put all this knowledge into practice? Here is the approach I use, which is grounded in the latest research and my clinical experience.

1. Comprehensive Lab Testing

A TSH-only screen is inadequate. I order a full panel that includes TSH, Free T4, Free T3, and Thyroid Antibodies (TPO and TgAb). If a patient is on T4-only medication and still has symptoms, I always order a Reverse T3 (RT3) test. This panel gives us the complete picture.

2. Choosing the Right Medication

The evidence and patient satisfaction surveys point to a clear conclusion: T4-only therapy is not effective for a significant portion of the population. A 2018 online survey of over 12,000 thyroid patients found that those taking Natural Desiccated Thyroid (NDT), which contains both T4 and T3 (such as NP Thyroid or Armor Thyroid), reported significantly higher satisfaction with their treatment (Peterson et al., 2018).

NDT is derived from porcine thyroid glands and contains T4 and T3 in a ratio very similar to the human thyroid. It provides the body with the active hormone it needs directly, bypassing potential conversion issues. When transitioning a patient from a synthetic T4 medication, I use a careful overlap protocol to allow the body to acclimate smoothly.

3. Standardizing Lab Draws and Dosing

T3 has a very short half-life of about 18-24 hours. To obtain meaningful and consistent data, testing must be standardized. I instruct all my patients to have their blood drawn five to six hours after taking their morning dose. This provides us with a consistent point on the absorption curve.

For my patients with Type 1 hypothyroidism—those without a functioning thyroid—a significant breakthrough has been the introduction of a second, afternoon dose of NDT. Because of T3’s short half-life, a single morning dose often leads to a “crash” by 3 or 4 p.m. By splitting their total daily dose, we maintain a more stable level of active T3, transforming their energy and quality of life.

The Critical, Overlooked Role of Iodine

I cannot overstate the importance of iodine for thyroid health and overall well-being. The Recommended Dietary Allowance (RDA) in the U.S. is a mere 150 micrograms, an amount established simply to prevent goiter, not to promote optimal health. In stark contrast, the average daily intake of iodine in Japan is over 13 milligrams (13,000 micrograms), primarily from seaweed. The correlation with cancer rates is alarming; Japan has significantly lower rates of breast and prostate cancer. As Dr. David Brownstein explains in his book, Iodine: Why You Need It, Why You Can’t Live Without It, this is likely not a coincidence.

Iodine is essential not just for the thyroid but for breast tissue, the prostate, ovaries, and every cell in the body. When you begin supplementing an iodine-deficient person, TSH will temporarily rise. This is the body’s intelligent response to produce more sodium-iodide symporters (NIS)—the gateways that pull iodine into the cells. An uninformed practitioner might see this TSH spike and wrongly conclude that the iodine is harmful. This is why I tell my patients we will not check a TSH level for at least nine months after starting iodine therapy. Free T3 and the patient’s symptoms are our true guides.

Integrative Chiropractic Care: The Neurological Connection

As a Doctor of Chiropractic (DC), I view the body through the lens of the nervous system as the master controller of all other systems, including the endocrine system. The connection among the spine, the nervous system, and thyroid function is a critical yet often-overlooked piece of the puzzle.

The thyroid gland receives its nerve supply from the cervical spine. Misalignments, or vertebral subluxations, in this area can interfere with the nerve signals traveling between the brain and the thyroid. This can disrupt the delicate feedback loop of the hypothalamic-pituitary-thyroid (HPT) axis.

How Chiropractic Fits In:

  • Restoring Nerve Function: Through specific, gentle chiropractic adjustments, we can correct subluxations in the cervical spine. This restores proper nerve flow, ensuring the brain and thyroid can communicate effectively. In my clinic, I have observed that patients receiving regular chiropractic care often see improvements in their thyroid function.
  • Reducing Systemic Stress: The chiropractic adjustment has a powerful effect on the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. Chronic stress elevates cortisol levels, which inhibit the conversion of T4 to T3. By modulating the stress response through chiropractic care, we create a more favorable hormonal environment for optimal thyroid function.
  • Holistic Support: Integrative chiropractic care encompasses nutritional counseling, lifestyle recommendations, and stress management techniques, all of which are foundational to supporting endocrine health.

By integrating chiropractic adjustments with functional medicine protocols, we address both the biochemical and neurological aspects of thyroid dysfunction, providing a truly comprehensive and powerful path to healing. Ultimately, our goal is not just to fix a lab value. It is to listen to our patients, to understand the deep physiological imbalances at play, and to use every evidence-based tool at our disposal to restore health and change lives.

References

Brownstein, D. (2014). Iodine: Why you need it, why you can’t live without it (5th ed.). Medical Alternatives Press.

Duntas, L. H., & Biondi, B. (2011). The aging thyroid: a challenge for the clinician. Nature Reviews Endocrinology, 7(9), 558–560. https://www.nature.com/articles/nrendo.2011.83

Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1997). Tissue-specific patterns of changes in 3,5,3′-triiodothyronine concentrations in hypothyroid rats. Endocrinology, 138(6), 2494-2503. https://doi.org/10.1210/endo.138.6.5186

Guo, T., Wang, Y., Zhang, Y., Ma, J., & Wang, F. (2022). Lower free triiodothyronine levels are associated with major depressive disorder and its symptom severity. Psychoneuroendocrinology, 146, 105952. https://doi.org/10.1016/j.psyneuen.2022.105952

Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., L’Abbate, A., & Donato, L. (2003). Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation, 107(5), 708–713. https://www.ahajournals.org/doi/10.1161/01.cir.0000048039.63811.23

Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2003). Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. The Journal of Clinical Endocrinology & Metabolism, 88(10), 4559–4565. https://academic.oup.com/jcem/article/88/10/4559/2845213

Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hescox, M., & … Bianco, A. C. (2018). An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid, 28(6), 707–721. https://doi.org/10.1089/thy.2017.0681

Pingitore, A., Iervasi, G., & Chopra, I. J. (2008). The role of thyroid hormone in the heart. Journal of Clinical Endocrinology & Metabolism, 93(6), 1957–1964.

Shakir, M. K., Brooks, B. A., & Crooks, L. A. (2007). The significance of a suppressed TSH in hypothyroid patients on levothyroxine. Endocrine Practice, 13(1), 16-20. https://doi.org/10.4158/EP.13.1.16

Starr, M. (2005). Hypothyroidism Type 2: The epidemic. Mark Starr Trust.

Woeber, K. A. (2002). Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. Journal of Endocrinology and Metabolism, 87(9), 3986-3990. https://doi.org/10.1210/jc.2002-020580